EP2308979A2 - Alpha-Amylase-Mutanten mit veränderten Eigenschaften - Google Patents

Alpha-Amylase-Mutanten mit veränderten Eigenschaften Download PDF

Info

Publication number
EP2308979A2
EP2308979A2 EP10181142A EP10181142A EP2308979A2 EP 2308979 A2 EP2308979 A2 EP 2308979A2 EP 10181142 A EP10181142 A EP 10181142A EP 10181142 A EP10181142 A EP 10181142A EP 2308979 A2 EP2308979 A2 EP 2308979A2
Authority
EP
European Patent Office
Prior art keywords
alpha
amylase
variant
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10181142A
Other languages
English (en)
French (fr)
Other versions
EP2308979A3 (de
Inventor
Thomas Thisted
Soeren Kjaerulff
Carsten Andersen
Claus Crone Fuglsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of EP2308979A2 publication Critical patent/EP2308979A2/de
Publication of EP2308979A3 publication Critical patent/EP2308979A3/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Definitions

  • the present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent alpha-amylase: stability under, e.g., high temperature and/or low pH conditions, in particular at low calcium concentrations.
  • the variant of the invention are suitable for starch conversion, ethanol production, laundry wash, dish wash, hard surface cleaning, textile desizing, and/or sweetner production.
  • Alpha-Amylases (alpha-1,4-glucan-4-glucanohydrolases, E.C. 3.2.1.1) constitute a group of enzymes, which catalyze hydrolysis of starch and other linear and branched 1,4-glucosidic oligo- and polysaccharides.
  • the object of the present invention is to provide Termamyl-like amylases which variants in comparison to the corresponding parent alpha-amylase, i.e., un-mutated alpha-amylase, has alpha-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent alpha-amylase: stability under, e.g., high temperature and/or low pH conditions, in particular at low calcium concentrations.
  • any amino acid residue may be substituted for the amino acid residue present in the position.
  • the alanine may be deleted or substituted for any other amino acid, i.e., any one of:
  • A30X means any one of the following substitutions: A30R, A30N, A30D, A30C, A30Q, A30E, A30G, A30H, A30I, A30L, A30K, A30M, A30F, A30P, A30S, A30T, A30W, A30Y, or A30 V; or in short: A30R, N, D, C, Q, E, G, H, I, L, K, M, F, P, S, T, W, Y, V .
  • Figure 1 is an alignment of the amino acid sequences of five parent Termamyl-like alpha-amylases. The numbers on the extreme left designate the respective amino acid sequences as follows:
  • the object of the present invention is to provide Termamyl-like amylases, which variants have alpha-amylase activity and exhibits altered stability at high temperatures and/or at low pH, in particular at low calcium concentrations.
  • alpha-amylases produced by Bacillus spp. are highly homologous (identical) on the amino acid level.
  • the B. licheniformis alpha-amylase comprising the amino acid sequence shown in SEQ ID NO: 8 (commercially available as Termamyl TM ) has been found to be about 81% homologous with the B. amyloliquefaciens alpha-amylase comprising the amino acid sequence shown in SEQ ID NO: 10 and about 65% homologous with the B. stearothermophilus alpha-amylase (BSG) comprising the amino acid sequence shown in SEQ ID NO: 6.
  • BSG B. stearothermophilus alpha-amylase
  • Further homologous alpha-amylases include SP690 and SP722 disclosed in WO 95/26397 and further depicted in SEQ ID NO: 2 and SEQ ID NO: 4, respectively, herein.
  • amylases are the AA560 alpha-amylase derived from Bacillus sp. and shown in SEQ ID NO: 12, and the #707 alpha-amylase derived from Bacillus sp., shown in SEQ ID NO: 13 and described by Tsukamoto et al., Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31 .
  • the KSM AP1378 alpha-amylase is disclosed in WO 97/00324 (from KAO Corporation).
  • alpha-amylases include the alpha-amylase produced by the B. licheniformis strain described in EP 0252666 (ATCC 27811), and the alpha-amylases identified in WO 91/00353 and WO 94/18314 .
  • Termamyl-like alpha-amylases are comprised in the products sold under the following tradenames: Optitherm TM and Takatherm TM (Solvay); Maxamyl TM (available from Gist-brocades/Genencor), Spezym AA TM and Spezyme Delta AATM (available from Genencor), and Keistase TM (available from Daiwa), Dex lo, GC 521 (available from Genencor) and Ultraphlow (from Enzyme Biosystems).
  • alpha-amylases Because of the substantial homology found between these alpha-amylases, they are considered to belong to the same class of alpha-amylases, namely the class of "Termamyl-like alpha-amylases".
  • Termamyl-like alpha-amylase is intended to indicate an alpha-amylase, in particular Bacillus alpha-amylase, which, at the amino acid level, exhibits a substantial identity to Termamyl TM , i.e., the B. licheniformis alpha-amylase having the amino acid sequence shown in SEQ ID NO: 8, herein.
  • alpha-amylases which has the amino acid sequences shown in SEQ ID NOS: 2, 4, 6, 8, 10, 12 and 13 herein are considered to be "Termamyl-like alpha-amylase".
  • Other Termamyl-like alpha-amylases are alpha-amylases i) which displays at least 60%, such as at least 70%, e.g., at least 75%, or at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99% homology (identity) with at least one of said amino acid sequences shown in SEQ ID NOS: 2, 4, 6, 8, 10, 12, and 13, and/or is encoded by a DNA sequence which hybridizes to the DNA sequences encoding the above-specified alpha-amylases which are apparent from SEQ ID NOS: 1, 3, 5, 7, 9, and of the present specification (which encoding sequences encode the amino acid sequences shown in SEQ ID NOS: 2, 4, 6, 8, 10 and 12 herein, respectively
  • the homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second.
  • the homology may suitably be determined by means of computer programs known in the art such as GAP provided in the GCG program package (described above).
  • GAP provided in the GCG program package (described above).
  • GAP creation penalty of 5.0 and GAP extension penalty of 0.3, respectively for nucleic acidic sequence comparison
  • GAP creation penalty of 3.0 and GAP extension penalty of 0.1 respectively, for protein sequence comparison.
  • GAP uses the method of Needleman and Wunsch, (1970), J.Mol. Biol. 48, p.443-453 , to make alignments and to calculate the identity.
  • a structural alignment between Termamyl (SEQ ID NO: 8) and, e.g., another alpha-amylase may be used to identify equivalent/corresponding positions in other Termamyl-like alpha-amylases.
  • One method of obtaining said structural alignment is to use the Pile Up programme from the GCG package using default values of gap penalties, i.e., a gap creation penalty of 3.0 and gap extension penalty of 0.1.
  • Other structural alignment methods include the hydrophobic cluster analysis ( Gaboriaud et al., (1987), FEBS LETTERS 224, pp. 149-155 ) and reverse threading ( Huber, T; Torda, AE, PROTEIN SCIENCE Vol. 7, No. 1 pp. 142-149 (1998 ).
  • oligonucleotide probe used in the characterisation of the Termamyl-like alpha-amylase above may suitably be prepared on the basis of the full or partial nucleotide or amino acid sequence of the alpha-amylase in question.
  • Suitable conditions for testing hybridisation involve presoaking in 5xSSC and prehybridizing for 1 hour at 40°C in a solution of 20% formamide, 5xDenhardt's solution, 50mM sodium phosphate, pH 6.8, and 50mg of denatured sonicated calf thymus DNA, followed by hybridisation in the same solution supplemented with 100 mM ATP for 18 hours at 40°C, followed by three times washing of the filter in 2xSSC, 0.2% SDS at 40°C for 30 minutes (low stringency), preferred at 50°C (medium stringency), more preferably at 65°C (high stringency), even more preferably at 75°C (very high stringency). More details about the hybridisation method can be found in Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989 .
  • derived from is intended not only to indicate an alpha-amylase produced or producible by a strain of the organism in question, but also an alpha-amylase encoded by a DNA sequence isolated from such strain and produced in a host organism transformed with said DNA sequence.
  • the term is intended to indicate an alpha-amylase, which is encoded by a DNA sequence of synthetic and/or cDNA origin and which has the identifying characteristics of the alpha-amylase in question.
  • the parent alpha-amylase may be a variant of a naturally occurring alpha-amylase, i.e., a variant, which is the result of a modification (insertion, substitution, deletion) of one or more amino acid residues of the naturally occurring alpha-amylase.
  • Termamy-like alpha-amylases may be used as the parent (i.e., backbone) alpha-amylase.
  • the parent alpha-amylase is derived from B. licheniformis, e.g., one of those referred to above, such as the B. licheniformis alpha-amylase having the amino acid sequence shown in SEQ ID NO: 8.
  • the parent alpha-amylase (i.e., backbone alpha-amylase) may also be a hybrid alpha-amylase, i.e., an alpha-amylase, which comprises a combination of partial amino acid sequences derived from at least two alpha-amylases.
  • the parent hybrid alpha-amylase may be one, which on the basis of amino acid homology (identity) and/or DNA hybridization (as defined above) can be determined to belong to the Termamyl-like alpha-amylase family.
  • the hybrid alpha-amylase is typically composed of at least one part of a Termamyl-like alpha-amylase and part(s) of one or more other alpha-amylases selected from Termamyl-like alpha-amylases or non-Termamyl-like alpha-amylases of microbial (bacterial or fungal) and/or mammalian origin.
  • the parent hybrid alpha-amylase may comprise a combination of partial amino acid sequences deriving from at least two Termamyl-like alpha-amylases, or from at least one Termamyl-like and at least one non-Termamyl-like bacterial alpha-amylase, or from at least one Termamyl-like and at least one fungal alpha-amylase.
  • the Termamyl-like alpha-amylase from which a partial amino acid sequence derives may be any of the specific Termamyl-like alpha-amylase referred to herein.
  • the parent alpha-amylase may comprise a C-terminal part of an alpha-amylase derived from a strain of B. licheniformis, and a N-terminal part of an alpha-amylase derived from a strain of B. amyloliquefaciens or from a strain of B. stearothermophilus.
  • the parent alpha-amylase may comprise at least 430 amino acid residues of the C-terminal part of the B. licheniformis alpha-amylase, and may, e.g., comprise a) an amino acid segment corresponding to the 37 N-terminal amino acid residues of the B.
  • amyloliquefaciens alpha-amylase having the amino acid sequence shown in SEQ ID NO: 10 and an amino acid segment corresponding to the 445 C-terminal amino acid residues of the B.
  • licheniformis alpha-amylase having the amino acid sequence shown in SEQ ID NO: 8, or a hybrid Termamyl-like alpha-amylase being identical to the Termamyl sequence, i.e., the Bacillus licheniformis alpha-amylase shown in SEQ ID NO: 8, except that the N-terminal 35 amino acid residues (of the mature protein) has been replaced by the N-terminal 33 residues of BAN (mature protein), i.e., the Bacillus amyloliquefaciens alpha-amylase shown in SEQ ID NO: 10; or b) an amino acid segment corresponding to the 68 N-terminal amino acid residues of the B.
  • stearothermophilus alpha-amylase having the amino acid sequence shown in SEQ ID NO: 6 and an amino acid segment corresponding to the 415 C-terminal amino acid residues of the B. licheniformis alpha-amylase having the amino acid sequence shown in SEQ ID NO: 8.
  • Another suitable parent hybrid alpha-amylase is the one previously described in WO 96/23874 (from Novo Nordisk) constituting the N-terminus of BAN, Bacillus amyloliquefaciens alpha-amylase (amino acids 1-300 of the mature protein) and the C-terminus from Termamyl (amino acids 301-483 of the mature protein).
  • the parent Termamyl-like alpha-amylase is a hybrid alpha-amylase of SEQ ID NO: 8 and SEQ ID NO: 10.
  • the parent hybrid Termamyl-like alpha-amylase may be a hybrid alpha-amylase comprising the 445 C-terminal amino acid residues of the B. licheniformis alpha-amylase shown in SEQ ID NO: 8 and the 37 N-terminal amino acid residues of the alpha-amylase derived from B.
  • amyloliquefaciens shown in SEQ ID NO: 10 which may suitably further have the following mutations: H156Y+A181T+N190F+A209V+Q264S (using the numbering in SEQ ID NO: 8).
  • the latter mentioned hybrid is used in the examples below and is referred to as LE174.
  • parent alpha-amylase include LE174 with fewer mutations, i.e., the right above mentioned hydrid having the following mutations: A181T+N190F+A209V+Q264S; N190F+A209V+Q264S; A209V+Q264S; Q264S; H156Y+N190F+A209V+Q264S; H156Y+A209V+Q264S; H156Y+Q264S; H156Y+A181T+A209V+Q264S; H156Y+A181T+Q264S; H156Y+Q264S; H156Y+A181T+N190F+Q264S; H156Y+A181T+N190F; H156Y+A181T+N190F; H156Y+A181T+N190F+A209V.
  • These hybrids are also considered to be part of the invention.
  • the parent Termamyl-like alpha amylase is LE174, SP722, or AA560 including any of LE174+G48A+T49I+G107A+I201F; LE174+M197L; LE174+G48A+T49I+G107A+M197L+I201F, or SP722+D183*+G184*; SP722+D183*+G184*+N195F; SP722+D183*+G184*+M202L; SP722+D183*+G184*+N195F+M202L; BSG+I181*+G182*; BSG+I181*+G182*+N193F; BSG+I181*+G182*+M200L; BSG+I181*+G182*+N193F+M200L; AA560+D183*+G184*; AA560+D183*+G184*+N195F; AA560+D183*+G184
  • LE429 which is LE174 with an additional substitution in I201F.
  • LE335 is the alpha-amylase, which in comparison to LE429 has additional substitutions in T49I+G107A;
  • LE399 is LE335+G48A, i.e., LE174, with G48A+T49I+G107A+I201F.
  • the invention relates to Termamyl-like alpha-amylases with altered properties (as mentioned above), in particular at high temperatures and/or at low pH, in particular at low calcium concentrations.
  • high temperature means temperatures from 70-120°C, preferably 80-100°C, especially 85-95°C.
  • low pH means from a pH in the range from 4-6, preferably 4.2-5.5, especially 4.5-5.
  • high pH means from a pH in the range from 8-11, especially 8.5-10.6.
  • low calcium concentration means free calcium levels lower than 60 ppm, preferably 40 ppm, more preferably 25 ppm, especially 5 ppm calcium.
  • Parent Termamyl-like alpha-amylase specifically contemplated in connection with going through the specifically contemplated altered properties are the above mentioned parent Termamyl-like alpha-amylase and parent hydrid Termamyl-like alpha-amylases.
  • the Termamyl® alpha-amylase is used as the starting point, but corresponding positions in, e.g., the SP722, BSG, BAN, AA560, SP690, KSM AP1378, and #707 should be understood as disclosed and specifically comtemplated too.
  • the variant of the invention has in particular at high temperatures and/or at low pH.
  • the invention relates to variant with altered properties as mentioned above.
  • a variant of a parent Termamyl-like alpha-amylase comprising an alteration at one or more positions (using SEQ ID NO: 8 for the amino acid numbering) selected from the group of:
  • Termamyl® (SEQ ID NO: 8) such corresponding positions are: T49; D60; N104; E132; D161; K170; K176; G179; K180; A181; D183; D200; Y203; D204; D207; 1212; K237; S239; E250; N280; Q298; L318; Q374; E385; Q393; Y402; H406; L427 D430; V440; N444; E447; Q482.
  • the variant of the invention (using SEQ ID NO: 8 (Termamyl TM ) for the numbering) has one or more of the following substitutions:
  • the variant of the invention (using SEQ ID NO: 4 (SP722) for the numbering) has one or more of the following substitutions:
  • Preferred double, triple and multi-mutations - using SEQ ID NO: 8 as the basis for the numbering - are selected from the group consisting of:
  • the variant has the following substitutions: K170Q+D207V+N280S; E132A+D207V; D207E+E250G+H406L+L427I; D207V+L318M; D60N+D207V+L318M; T49I+E132V+V440A; T49I+K176R+D207V+Y402F; Q374R+E385V+Q393R; N190F+A209V+Q264S; G48A+T49I+G107A+I201F; T49I+G107A+I201F; G48A+T49I+I201F; G48A+T49I+G107A; T49I+I201F; T49I+G107A; G48A+T49I; D161N+G179N+K180T+A181N+D183N+D200N+D204S+K237P+S239W+H406W+ D430N
  • mutations including amino acid substitutionsa and deletion
  • improved stability i.e., higher or lower
  • high temperatures i.e., 70-120°C
  • extreme pH i.e. low or high pH, i.e, pH 4-6 or pH 8-11, respectively
  • free calcium concentrations below 60 ppm include any of the mutations listed in the "Altered properties” section.
  • the stability may be determined as described in the "Materials & Methods" section below.
  • a variant of the invention may in one embodiment comprise one or more modifications in addition to those outlined above.
  • one or more Proline (Pro) residues present in the part of the alpha-amylase variant which is modified is/are replaced with a non-Proline residue which may be any of the possible, naturally occurring non-Proline residues, and which preferably is an Alanine, Glycine, Serine, Threonine, Valine or Leucine.
  • one or more Cysteine residues present in the parent alpha-amylase may be replaced with a non-Cysteine residue such as Serine, Alanine, Threonine, Glycine, Valine or Leucine.
  • a variant of the invention may - either as the only modification or in combination with any of the above outlined modifications - be modified so that one or more Asp and/or Glu present in an amino acid fragment corresponding to the amino acid fragment 185-209 of SEQ ID NO: 10 is replaced by an Asn and/or Gln, respectively. Also of interest is the replacement, in the Termamyl-like alpha-amylase, of one or more of the Lys residues present in an amino acid fragment corresponding to the amino acid fragment 185-209 of SEQ ID NO: 10 by an Arg.
  • the DNA sequence encoding a parent alpha-amylase may be isolated from any cell or microorganism producing the alpha-amylase in question, using various methods well known in the art.
  • a genomic DNA and/or cDNA library should be constructed using chromosomal DNA or messenger RNA from the organism that produces the alpha-amylase to be studied.
  • homologous, labeled oligonucleotide probes may be synthesized and used to identify alpha-amylase-encoding clones from a genomic library prepared from the organism in question.
  • oligonucleotide probe containing sequences homologous to a known alpha-amylase gene could be used as a probe to identify alpha-amylase-encoding clones, using hybridization and washing conditions of lower stringency.
  • Yet another method for identifying alpha-amylase-encoding clones would involve inserting fragments of genomic DNA into an expression vector, such as a plasmid, transforming alpha-amylase-negative bacteria with the resulting genomic DNA library, and then plating the transformed bacteria onto agar containing a substrate for alpha-amylase, thereby allowing clones expressing the alpha-amylase to be identified.
  • an expression vector such as a plasmid
  • transforming alpha-amylase-negative bacteria with the resulting genomic DNA library
  • the DNA sequence encoding the enzyme may be prepared synthetically by established standard methods, e.g., the phosphoroamidite method described by S.L. Beaucage and M.H. Caruthers, Tetrahedron Letters 22, 1981, pp. 1859-1869 , or the method described by Matthes et al., The EMBO J. 3, 1984, pp. 801-805 .
  • the phosphoroamidite method oligonucleotides are synthesized, e.g., in an automatic DNA synthesizer, purified, annealed, ligated and cloned in appropriate vectors.
  • the DNA sequence may be of mixed genomic and synthetic origin, mixed synthetic and cDNA origin or mixed genomic and cDNA origin, prepared by ligating fragments of synthetic, genomic or cDNA origin (as appropriate, the fragments corresponding to various parts of the entire DNA sequence), in accordance with standard techniques.
  • the DNA sequence may also be prepared by polymerase chain reaction (PCR) using specific primers, for instance as described in US 4,683,202 or R.K. Saiki et al., Science 239, 1988, pp. 487-491 .
  • mutations may be introduced using synthetic oligonucleotides. These oligonucleotides contain nucleotide sequences flanking the desired mutation sites; mutant nucleotides are inserted during oligonucleotide synthesis.
  • a single-stranded gap of DNA, bridging the alpha-amylase-encoding sequence is created in a vector carrying the alpha-amylase gene.
  • the synthetic nucleotide, bearing the desired mutation is annealed to a homologous portion of the single-stranded DNA.
  • Alternative methods for providing variants of the invention include gene shuffling, e.g., as described in WO 95/22625 (from Affymax Technologies N.V.) or in WO 96/00343 (from Novo Nordisk A/S), or other corresponding techniques resulting in a hybrid enzyme comprising the mutation(s), e.g., substitution(s) and/or deletion(s), in question.
  • parent alpha-amylases which suitably may be used for providing a hybrid with the desired mutations(s) according to the invention include the KSM-K36 and KSM-K38 alpha-amylases disclosed in EP 1,022,334 (hereby incorporated by reference).
  • a DNA sequence encoding the variant produced by methods described above, or by any alternative methods known in the art can be expressed, in enzyme form, using an expression vector which typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
  • the recombinant expression vector carrying the DNA sequence encoding an alpha-amylase variant of the invention may be any vector, which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e., a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, a bacteriophage or an extrachromosomal element, minichromosome or an artificial chromosome.
  • the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated.
  • the DNA sequence should be operably connected to a suitable promoter sequence.
  • the promoter may be any DNA sequence, which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • Suitable promoters for directing the transcription of the DNA sequence encoding an alpha-amylase variant of the invention, especially in a bacterial host are the promoter of the lac operon of E.coli, the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis alpha-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus amyloliquefaciens alpha-amylase (amyQ), the promoters of the Bacillus subtilis xy1A and xylB genes etc.
  • useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral alpha-amylase, A. niger acid stable alpha-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase.
  • the expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the alpha-amylase variant of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
  • the vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
  • a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110, pE194, pAMB1 and pIJ702.
  • the vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • a selectable marker e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, e.g., as described in WO 91/17243 .
  • Bacillus alpha-amylases mentioned herein comprise a preregion permitting secretion of the expressed protease into the culture medium. If desirable, this preregion may be replaced by a different preregion or signal sequence, conveniently accomplished by substitution of the DNA sequences encoding the respective preregions.
  • the cell of the invention is advantageously used as a host cell in the recombinant production of an alpha-amylase variant of the invention.
  • the cell may be transformed with the DNA construct of the invention encoding the variant, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
  • the cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g., a bacterial or a fungal (including yeast) cell.
  • a microbial cell e.g., a bacterial or a fungal (including yeast) cell.
  • suitable bacteria are Gram-positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis, or Streptomyces lividans or Streptomyces murinus, or gramnegative bacteria such as E.coli.
  • the transformation of the bacteria may, for instance, be effected by protoplast transformation or by using competent cells in a manner known per se.
  • the yeast organism may favorably be selected from a species of Saccharomyces or Schizosaccharomyces, e.g. Saccharomyces cerevisiae.
  • the filamentous fungus may advantageously belong to a species of Aspergillus, e.g., Aspergillus oryzae or Aspergillus niger.
  • Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023 .
  • the present invention relates to a method of producing an alpha-amylase variant of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the variant and recovering the variant from the cells and/or culture medium.
  • the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the alpha-amylase variant of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
  • the alpha-amylase variant secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • alpha-amylase variants of this invention possess valuable properties allowing for a variety of industrial applications.
  • enzyme variants of the invention are applicable as a component in washing, dishwashing, and hard surface cleaning detergent compositions.
  • Variant of the invention with altered properties may be used for starch processes, in particular starch conversion, especially liquefaction of starch (see, e.g., US 3,912,590 , EP patent publications Nos. 252 730 and 63 909 , WO 99/19467 , and WO 96/28567 all references hereby incorporated by reference).
  • compositions for starch conversion purposes which may beside the variant of the invention also comprise a AMG, pullulanase, and other alpha-amylases.
  • variants of the invention are also particularly useful in the production of sweeteners and ethanol (see, e.g., US patent no. 5,231,017 hereby incorporated by reference), such as fuel, drinking and industrial ethanol, from starch or whole grains.
  • a variant of the invention may also be used for textile desizing (see, e.g., WO 95/21247 , US patent 4,643,736 , EP 119,920 hereby in corporate by reference).
  • variants of the invention may suitably be incorporated in detergent compositions.
  • Detergent compositions comprising a variant of the invention may additionally comprise one or more other enzymes, such as a protease, a lipase, a peroxidase, another amylolytic enzyme, glucoamylase, maltogenic amylase, CGTase and/or a cellulase, mannanase (such as Mannaway TM from Novozymes, Denmark)), pectinase, pectine lyase, cutinase, laccase, and/or another alpha-amylase.
  • enzymes such as a protease, a lipase, a peroxidase, another amylolytic enzyme, glucoamylase, maltogenic amylase, CGTase and/or a cellulase, mannanase (such as Mannaway TM from Novozymes, Denmark)), pectinase, pectine lyase, cutinase
  • Alpha-amylase variants of the invention may be incorporated in detergents at conventionally employed concentrations. It is at present contemplated that a variant of the invention may be incorporated in an amount corresponding to 0.00001-10 mg (calculated as pure, active enzyme protein) of alpha-amylase per liter of wash/dishwash liquor using conventional dosing levels of detergent.
  • the invention also related to composition comprising a variant of the invention, and in a preferred embodiment also a B. stearothermophilus alpha-amylase (BSG), in particular a variant thereof.
  • BSG B. stearothermophilus alpha-amylase
  • the composition comprises beside a variant of the invention a glucoamylase, in particular a glucoamylase originating from Aspergillus niger (e.g., the G1 or G2 A. niger AMG disclosed in Boel et al. (1984), "Glucoamylases G1 and G2 from Aspergillus niger are synthesized from two different but closely related mRNAs", EMBO J. 3 (5), p. 1097-1102 , or a variant therefore, in particular a variant disclosed in WO 00/04136 or WO 01/04273 or the Talaromyces emersonii AMG disclosed in WO 99/28448 .
  • a glucoamylase in particular a glucoamylase originating from Aspergillus niger (e.g., the G1 or G2 A. niger AMG disclosed in Boel et al. (1984), "Glucoamylases G1 and G2 from As
  • a specific combination is LE399 and a variant disclosed in WO 00/04136 or Wo 01/04273 , in particular a variant with oe or more of the following substitutions:
  • composition of the invention also comprises a pullulanase, in particular a Bacillus pullulanase.
  • AA560 SEQ ID NO: 12; disclosed in WO 00/60060 ; deposited on 25th January 1999 at DSMZ and assigned the DSMZ no. 12649. AA560 were deposited by the inventors under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at Deutshe Sammmlung von Microorganismen und Zellkulturen GmbH (DSMZ), Mascheroder Weg 1b, D-38124 Braunschweig DE.
  • DSMZ Sammmlung von Microorganismen und Zellkulturen GmbH
  • LB medium In 1 liter H20: 10 g bacto-tryptone, 5 g bacto-yeast extract, 10 g NaCl, pH adjusted to 7.0 w. NaOH, autoclaved).
  • TY agar plates In 1 liter H20: 16 g bacto-tryptone, 10 g bacto-yeast extract, 5 g NaCl, pH adjusted to 7.0 w. NaOH, and 15 g bacto-agar is added prior to autoclaving).
  • Bacillus subtilis SHA273 see WO 95/10603
  • pDN1528 contains the complete gene encoding Termamyl, amyL, the expression of which is directed by its own promoter. Further, the plasmid contains the origin of replication, ori, from plasmid pUB110 and the cat gene from plasmid pC194 conferring resistance towards chloramphenicol. pDN1528 is shown in Fig. 9 of WO 96/23874 .
  • Bacillus libraries are plated on a sandwich of cellulose acetate (OE 67, Schleicher & Schuell, Dassel, Germany) - and nitrocellulose filters (Protran-Ba 85, Schleicher & Schuell, Dassel, Germany) on TY agar plates with 10 micro g/ml chloramphenicol at 37°C for at least 21 hours.
  • the cellulose acetate layer is located on the TY agar plate.
  • Each filter sandwich is specifically marked with a needle after plating, but before incubation in order to be able to localize positive variants on the filter, and the nitrocellulose filter with bound variants is transferred to a container with citrate buffer, pH 4.5 and incubated at 80°C for 20 minutes (when screening for variants in the wild type backbone) or 85oC for 60 minutes (when screening for variants in the LE399 backbone).
  • the cellulose acetate filters with colonies are stored on the TY-plates at room temperature until use. After incubation, residual activity is detected on assay plates containing 1% agarose, 0.2% starch in citrate buffer, pH 6.0.
  • the assay plates with nitrocellulose filters are marked the same way as the filter sandwich and incubated for 2 hours at 50°C. After removal of the filters the assay plates are stained with 10% Lugol solution. Starch degrading variants are detected as white spots on dark blue background and then identified on the storage plates. Positive variants are re-screened twice under the same conditions as the first screen
  • Positive transformants after rescreening are picked from the storage plate and tested in a secondary plate assay. Positive transformants are grown for 22 hours at 37°C in 5 ml LB + chloramphenicol. The Bacillus culture of each positive transformant and as a control a clone expressing the corresponding backbone are incubated in citrate buffer, pH 4.5 at 90°C and samples are taken at 0, 10, 20, 30, 40, 60 and 80 minutes. A 3 micro liter sample is spotted on an assay plate. The assay plate is stained with 10% Lugol solution. Improved variants are seen as variants with higher residual activity (detected as halos on the assay plate) than the backbone. The improved variants are determined by nucleotide sequencing.
  • a B. subtilis strain harbouring the relevant expression plasmid is streaked on a LB-agar plate with 10 micro g/ml kanamycin from -80°C stock, and grown overnight at 37°C.
  • the colonies are transferred to 100 ml PS-1 media supplemented with 10 micro g/ml chloamphinicol in a 500 ml shaking flask.
  • Composition of PS-1 medium Pearl sugar 100 g/l Soy Bean Meal 40 g/l Na2HPO4, 12 H2O 10 g/l PluronicTM PE 6100 0.1 g/l CaCO3 5 g/l
  • the culture is shaken at 37°C at 270 rpm for 5 days.
  • the enzyme is incubated under the relevant conditions (1-4). Samples are taken at various time points, e.g., after 0, 5, 10, 15 and 30 minutes and diluted 25 times (same dilution for all taken samples) in assay buffer (0.1M 50mM Britton buffer pH 7.3) and the activity is measured using the Phadebas assay (Pharmacia) under standard conditions pH 7.3, 37°C.
  • assay buffer 0.1M 50mM Britton buffer pH 7.3
  • the activity measured before incubation (0 minutes) is used as reference (100%).
  • the decline in percent is calculated as a function of the incubation time.
  • the table shows the residual activity after, e.g., 30 minutes of incubation.
  • Phadebas® tablets Phadebas tablets (Phadebas® Amylase Test, supplied by Pharmacia Diagnostic) contain a crosslinked insoluble blue-colored starch polymer, which has been mixed with bovine serum albumin and a buffer substance and tabletted.
  • the measured 620 nm absorbance after 10 or 15 minutes of incubation is in the range of 0.2 to 2.0 absorbance units at 620 nm. In this absorbance range there is linearity between activity and absorbance (Lambert-Beer law). The dilution of the enzyme must therefore be adjusted to fit this criterion. Under a specified set of conditions (temp., pH, reaction time, buffer conditions) 1 mg of a given alpha-amylase will hydrolyze a certain amount of substrate and a blue colour will be produced. The colour intensity is measured at 620 nm. The measured absorbance is directly proportional to the specific activity (activity/mg of pure alpha-amylase protein) of the alpha-amylase in question under the given set of conditions.
  • Alpha-amylase activity is determined by a method employing the PNP-G7 substrate.
  • PNP-G7 which is a abbreviation for p-nitrophenyl-alpha,D-maltoheptaoside is a blocked oligosaccharide which can be cleaved by an endo-amylase.
  • Kits containing PNP-G7 substrate and alpha-Glucosidase is manufactured by Boehringer-Mannheim (cat. No.1054635).
  • reagent solution 10 ml of substrate/buffer solution is added to 50 ml enzyme/buffer solution as recommended by the manufacturer.
  • the assay is performed by transferring 20 micro 1 sample to a 96 well microtitre plate and incubating at 25°C. 200 micro 1 reagent solution pre-equilibrated to 25°C is added. The solution is mixed and pre-incubated 1 minute and absorption is measured every 30 sec. over 4 minutes at OD 405 nm in an ELISA reader.
  • the slope of the time dependent absorption-curve is directly proportional to the activity of the alpha-amylase in question under the given set of conditions.
  • the plasmid pDN1528 encoding the wild-type Bacillus licheniformis alpha-amylase gene was utilized as template to amplify this gene with primers: 22149: 5'-CGA TTG CTG ACG CTG TTA TTT GCG-3' (SEQID NO: 14) and 24814: 5'-GAT CAC CCG CGA TAC CGT C-3' (SEQ ID NO: 15) under PCR conditions where increased error rates leads to introduction of random point mutations.
  • the PCR conditions utilized were: 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 4 mM MgC12, 0.3 mM MnC12, 0.lmM dGTP/dATP, 0.5 mM dTTP/dCTP, and 2.5 units Taq polymerase per 100 micro 1 reaction.
  • the resultant PCR fragment was purified on gel and used in a PCR-based multimerization step with a gel purified vector fragment created by PCR amplification of pDN1528 with primers #24: 5'-GAA TGT ATG TCG GCC GGC AAA ACG CCG GTG A-3' (SEQ ID NO: 16) and #27: 5'-GCC GCC GCT GCT GCA GAA TGA GGC AGC AAG-3' (SEQ ID NO:17) forming an overlap to the insert fragment.
  • the multimerization reaction was subsequently introduced into B. subtilis ( Shafikhani et al., Biotechniques, 23 (1997), 304-310 ).
  • LE493 Mutations from LE493 (K176R+D207V+Y402F) were transferred to LE399 yielding LE495. This was performed by the overlap PCR method ( Kirchhoff and Desrosiers, PCR Methods and Applications, 2 (1993), 301-304 ).
  • Fragment A #312 Mut176 5'-CCC GAA AGC TGA ACC GCA TCT ATA GGT TTC AAG GGA AGA CTT GGG ATT-3' (SEQ ID NO: 18) (mutated codon indicated in bold) and #290 D207overlap 5'-AGG ATG GTC ATA ATC AAA GTC GG-3'(SEQ ID NO: 19); Fragment B: #313 Mut207 5'-CCG ACT TTG ATT ATG ACC ATC CTG TTG TCG TAG CAG AGA TTA AGA GAT GGG G-3' (SEQ ID NO: 20) and #314 Mut402 5'-CGA CAA TGT CAT GGT GGT CGA AAA AAT CAT GCT GTG CTC CGT ACG-3' (SEQ ID NO: 21).
  • Fragments A and B were mixed in equimolar ratios and subsequently the full-length fragment was amplified with the external primers: #312 Mut176 and #314 Mut402.
  • This fragment was used in a multimerization reaction with the vector PCR fragment created with the primers #296 Y402multi 5'-TTT CGA CCA CCA TGA CAT TGT CG-3' (SEQ ID NO: 22) and #305 399Multi176 5'-TAT AGA TGC GGT TCA GCT TTC GGG-3' (SEQ ID NO: 23) on template LE399 as described above.
  • the multimerization reaction was subsequently transformed into B. subtilis. Clones were screened for stability in the assay mentioned above. The presence of the mutations from LE493 in several clones with increased stability was confirmed by sequencing.
  • LE 497 was obtained in a similar manner by amplifying the LE399 encoding template with primers #312 Mut176 and #314 Mut402 and using the resulting PCR fragment in a multimerization reaction with a vector fragment obtained by PCR amplification of the LE399 template with the primers #296 Y402multi and #305 399Multi176.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP10181142A 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften Withdrawn EP2308979A3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001160 2000-08-01
DKPA200001354 2000-09-12
DKPA200001687 2000-11-10
DKPA200100655 2001-04-26
EP01956424A EP1370648A2 (de) 2000-08-01 2001-07-12 Alpha-amylase-mutanten mit veränderten eigenschaften

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP01956424.4 Division 2001-07-12

Publications (2)

Publication Number Publication Date
EP2308979A2 true EP2308979A2 (de) 2011-04-13
EP2308979A3 EP2308979A3 (de) 2011-05-04

Family

ID=27439820

Family Applications (6)

Application Number Title Priority Date Filing Date
EP10181953A Withdrawn EP2298903A3 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP01956424A Withdrawn EP1370648A2 (de) 2000-08-01 2001-07-12 Alpha-amylase-mutanten mit veränderten eigenschaften
EP10181142A Withdrawn EP2308979A3 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP09178946A Ceased EP2180035A1 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP10181164A Withdrawn EP2308980A3 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP09176569A Withdrawn EP2204446A1 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP10181953A Withdrawn EP2298903A3 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP01956424A Withdrawn EP1370648A2 (de) 2000-08-01 2001-07-12 Alpha-amylase-mutanten mit veränderten eigenschaften

Family Applications After (3)

Application Number Title Priority Date Filing Date
EP09178946A Ceased EP2180035A1 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP10181164A Withdrawn EP2308980A3 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften
EP09176569A Withdrawn EP2204446A1 (de) 2000-08-01 2001-07-12 Alpha-Amylase-Mutanten mit veränderten Eigenschaften

Country Status (7)

Country Link
EP (6) EP2298903A3 (de)
JP (2) JP4855632B2 (de)
CN (2) CN1529752A (de)
AR (2) AR028979A1 (de)
AU (1) AU2001278415A1 (de)
CA (3) CA2702204C (de)
WO (1) WO2002010355A2 (de)

Families Citing this family (507)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154142A0 (en) 2000-07-28 2003-07-31 Henkel Kgaa Novel amylolytic enzyme extracted from bacillus sp.a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic
US20040091994A1 (en) * 2000-10-13 2004-05-13 Carsten Andersen Alpha-amylase variant with altered properties
WO2002031124A2 (en) * 2000-10-13 2002-04-18 Novozymes A/S Alpha-amylase variant with altered properties
EP3000881A3 (de) 2001-05-15 2016-07-20 Novozymes A/S Alpha-Amylasevariante mit veränderten Eigenschaften
EP2500423B1 (de) * 2003-02-26 2015-06-17 Danisco US Inc. Amylasen, die eine veränderte immunogene Reaktion bewirken, und Verfahren zu ihrer Herstellung und Verwendung
US7579177B2 (en) 2003-05-30 2009-08-25 Novozymes A/S Alcohol product processes
DE102004048591A1 (de) * 2004-04-27 2005-11-24 Henkel Kgaa Reinigungsmittel mit Klarspültensid und einer speziellen α-Amylase
CA2571864C (en) * 2004-07-05 2014-09-23 Novozymes A/S Alpha-amylase variants with altered properties
BRPI0516653A2 (pt) * 2004-12-02 2012-07-31 Novozymes North America Inc processo para desengomar um pano engomado contendo amido ou derivados de amido durante a manufatura de um pano
MX2007007107A (es) 2004-12-22 2007-08-08 Novozymes North America Inc Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que los codifican.
DK1926753T3 (da) 2004-12-22 2011-03-14 Novozymes As Hybridenzymer, der består af en endoamylase som første aminosyresekvens og et kulhydratbindingsmodul som anden aminosyresekvens
CN100415879C (zh) * 2005-06-22 2008-09-03 天津科技大学 耐酸耐高温的α-淀粉酶及其制备方法
CN101268195A (zh) 2005-09-20 2008-09-17 诺维信北美公司 产生发酵产物的方法
WO2007076388A2 (en) 2005-12-22 2007-07-05 Novozymes North America, Inc. Processes for producing a fermentation product
DE102006038448A1 (de) * 2005-12-28 2008-02-21 Henkel Kgaa Enzym-haltiges Reinigungsmittel
US8076112B2 (en) 2006-03-22 2011-12-13 Novozymes A/S Fermentation processes
EP2066785B1 (de) 2006-08-11 2023-02-01 Novozymes Biologicals, Inc. Bakterienkulturen und zusammensetzungen mit bakterienkulturen
ES2513217T3 (es) * 2007-02-07 2014-10-24 Danisco Us, Inc., Genencor Division Fitasas de Buttiauxella sp. variantes que tienen propiedades alteradas
BRPI0808513A2 (pt) 2007-03-09 2014-08-19 Danisco Us Inc Genencor Div Variantes de alfa-amilase de espécies de bacillus alcalifílico, composições compreendendo variantes de alfa-amilase e métodos de uso
MX2009009967A (es) 2007-03-23 2009-10-07 Danisco Us Inc Genencor Div Produccion mejorada de amilasa por adicion n-terminal a proteina amilasa madura.
WO2008118749A2 (en) 2007-03-23 2008-10-02 Novozymes Biologicals, Inc. Preventing and reducing biofilm formation and planktonic proliferation
EP3219804B1 (de) 2007-04-24 2019-07-17 Novozymes North America, Inc. Entgiftung von vorbehandelten lignocellulosehaltigen materialen
CN101796247B (zh) 2007-09-03 2014-01-22 诺维信公司 脱毒和再循环在含木素纤维素材料的预处理中使用的洗涤溶液
EP2212410B1 (de) 2007-11-05 2016-08-10 Danisco US Inc. Varianten der Alpha-amylase aus Bacillus Licheniformis mit erhöhter Thermostabilität und/oder reduzierter Calciumabhängigkeit
WO2009061380A2 (en) 2007-11-05 2009-05-14 Danisco Us Inc., Genencor Division VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES
AU2008325249B2 (en) * 2007-11-05 2013-10-10 Danisco Us Inc. Alpha-amylase variants with altered properties
MX2010008359A (es) 2008-02-04 2010-08-30 Danisco Us Inc Variantes de alfa-amilasa ts23 con propiedades alteradas.
EP2100948A1 (de) * 2008-03-14 2009-09-16 The Procter and Gamble Company Waschmittelzusammensetzung für Spülmaschinen
EP2100947A1 (de) 2008-03-14 2009-09-16 The Procter and Gamble Company Waschmittelzusammensetzung für Spülmaschinen
CA2726688A1 (en) 2008-06-23 2010-01-21 Novozymes A/S Processes for producing fermentation products
EP2149786A1 (de) 2008-08-01 2010-02-03 Unilever PLC Verbesserungen bei der Analyse von Reinigungsmitteln
DE212009000119U1 (de) 2008-09-12 2011-12-30 Unilever N.V. Spender und Vorbehandlungsmittel für viskose Flüssigkeiten
US20110165617A1 (en) 2008-09-30 2011-07-07 Novozymes North America, Inc. Enzymatic Hydrolysis Of Pretreated Lignocellulose-Containing Material With Distillers Dried Grains
WO2010059413A2 (en) 2008-11-20 2010-05-27 Novozymes, Inc. Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
EP2202290A1 (de) 2008-12-23 2010-06-30 Unilever PLC Fließfähige Waschmittelzusammensetzung und Verpackung dafür
EP2384365A2 (de) 2008-12-30 2011-11-09 Novozymes North America, Inc. Verbesserung der enzymatischen hydrolyse von vorbehandeltem lignocellulosehaltigem material mit entspannungsflotationsschlamm
WO2010078392A2 (en) 2008-12-31 2010-07-08 Novozymes North America, Inc. Processes of producing fermentation products
CA2768315A1 (en) 2009-07-17 2011-01-20 Novozymes A/S A method of analyzing cellulose decay in cellulosic material hydrolysis
CN102869770B (zh) 2009-11-30 2015-12-16 诺维信公司 具有葡糖淀粉酶活性的多肽和编码该多肽的多核苷酸
CA2782154C (en) 2009-11-30 2018-10-16 Novozymes A/S Polypeptides having glucoamylase activity and polynucleotides encoding same
CA2782036C (en) 2009-12-01 2019-01-15 Novozymes A/S Polypeptides having glucoamylase activity and polynucleotides encoding same
CN102933227A (zh) 2009-12-22 2013-02-13 诺维信公司 包含增强性多肽和淀粉降解酶的组合物及其用途
CN102884183B (zh) 2010-01-04 2015-09-16 诺维信公司 趋于钙耗竭和酸性pH的α-淀粉酶的稳定化
EP2529022A1 (de) 2010-01-29 2012-12-05 Novozymes A/S Biogasherstellungsverfahren mit enzymatischer vorbehandlung
WO2011100161A1 (en) 2010-02-09 2011-08-18 Novozymes North America, Inc. Addition of alpha - glucosidase and cobalt for producing fermentation products from starch
EP2357220A1 (de) * 2010-02-10 2011-08-17 The Procter & Gamble Company Reinigungszusammensetzungen mit Amylasevarianten mit hoher Stabilität in Gegenwart eines Chelatwirkstoffs
EP3892709A3 (de) * 2010-02-10 2022-01-19 Novozymes A/S Varianten und zusammensetzungen mit varianten mit hoher stabilität in gegenwart eines chelatwirkstoffs
CN102834521B (zh) 2010-03-30 2018-02-27 诺维信公司 用于增强来自发酵工艺副产物的方法
CA2795806C (en) 2010-04-14 2019-01-08 Novozymes A/S Polypeptides having glucoamylase activity and polynucleotides encoding same
EP2601301A1 (de) 2010-08-02 2013-06-12 Novozymes North America, Inc. Verfahren zur herstellung eines gärungsproduktes
GB201015672D0 (en) 2010-09-20 2010-10-27 Unilever Plc Improvements relating to fabric treatment compositions comprising targeted benefit agents
DK2638154T3 (da) 2010-11-08 2017-01-02 Novozymes As Polypeptider med glucoamylaseaktivitet og polynukleotider, der koder for dem
EP2637515B1 (de) 2010-11-08 2017-09-06 Novozymes A/S Polypeptide mit glucoamylaseaktivität und dafür codierende polynukleotide
CA2817224A1 (en) 2010-11-19 2012-05-24 Novozymes North America, Inc. Processes of producing a fermentation product
CN103339260A (zh) 2011-01-04 2013-10-02 诺维信公司 从含果胶和木素纤维素的材料产生生物气的方法
US9677094B2 (en) 2011-02-07 2017-06-13 Novozymes A/S Process of producing a fermentation product
CA2827405C (en) 2011-02-15 2023-01-10 Novozymes Biologicals, Inc. Mitigation of odor in cleaning machines and cleaning processes
WO2013000945A1 (en) 2011-06-28 2013-01-03 Novozymes A/S Biogas from enzyme-treated bagasse
EP2540824A1 (de) * 2011-06-30 2013-01-02 The Procter & Gamble Company Reinigungszusammensetzungen mit Amylasevariantenreferenz zu einem Sequenzprotokoll
EP2726500B1 (de) * 2011-06-30 2019-03-20 Novozymes A/S Verfahren zum screening von alpha-amylasen
EP3421595B1 (de) * 2011-06-30 2020-10-07 Novozymes A/S Alpha-amylase-varianten
MX337984B (es) 2011-07-06 2016-03-30 Novozymes As Variantes de alfa amilasa y polinucleotidos que codifican la misma.
CN109022518A (zh) 2011-07-22 2018-12-18 诺维信北美公司 用于预处理纤维素材料和改进其水解的方法
CA2846690A1 (en) 2011-08-26 2013-03-07 Novozymes A/S Polypeptides having glucoamylase activity and polynucleotides encoding same
CN103930543B (zh) 2011-09-06 2020-11-27 诺维信公司 葡糖淀粉酶变体和编码它们的多核苷酸
US9353362B2 (en) 2011-10-11 2016-05-31 Novozymes A/S Glucoamylase variants and polynucleotides encoding same
EP2766490B1 (de) 2011-10-11 2017-04-12 Novozymes North America, Inc. Verflüssigungsverfahren zur herstellung von gärungsprodukten
HUE039835T2 (hu) 2011-10-17 2019-02-28 Novozymes As Alfa-amiláz variánsok és az azokat kódoló polinukleotidok
CA3253390A1 (en) 2011-10-17 2025-06-17 Novozymes A/S Variants of alpha-amylase and the polynucleotides encoding them
EP3845641A1 (de) 2011-10-28 2021-07-07 Danisco US Inc. Alpha-amylase-varianten zur bildung von varianter maltohexaosevariante
IN2014CN04905A (de) 2011-12-02 2015-09-18 Novozymes As
WO2013083801A2 (en) 2011-12-09 2013-06-13 Novozymes A/S Biogas from substrates comprising animal manure and enzymes
WO2013096652A1 (en) 2011-12-21 2013-06-27 Novozymes, Inc. Methods for determining the degradation of a biomass material
US9801398B2 (en) 2012-01-26 2017-10-31 Novozymes A/S Use of polypeptides having protease activity in animal feed and detergents
CA2869047C (en) 2012-03-30 2022-11-01 Novozymes North America, Inc. Processes of producing fermentation products
CN113201519A (zh) 2012-05-07 2021-08-03 诺维信公司 具有黄原胶降解活性的多肽以及编码其的核苷酸
WO2013171241A1 (en) 2012-05-16 2013-11-21 Novozymes A/S Compositions comprising lipase and methods of use thereof
MX364390B (es) 2012-06-20 2019-04-25 Novozymes As Uso de polipeptidos que tienen actividad proteasa en alimentos para animales y detergentes.
US9828595B2 (en) 2012-08-17 2017-11-28 Novozymes A/S Thermostable asparaginase variants and polynucleotides encoding same
MX2015002211A (es) 2012-08-22 2015-05-08 Novozymes As Metaloproteasa de exiguobacterium.
US9315791B2 (en) 2012-08-22 2016-04-19 Novozymes A/S Metalloproteases from alicyclobacillus
TR201910918T4 (tr) 2012-12-07 2019-08-21 Novozymes As Bakterilerin yapışmasının önlenmesi.
US9551042B2 (en) 2012-12-21 2017-01-24 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
EP3321360A3 (de) 2013-01-03 2018-06-06 Novozymes A/S Alpha-amylase-varianten und polynukleotide zur codierung davon
ES2676895T5 (es) 2013-03-11 2022-04-27 Danisco Us Inc Variantes combinatorias de alfa-amilasa
WO2014173980A2 (en) 2013-04-23 2014-10-30 Novozymes A/S Liquid automatic dish washing detergent compositions
EP3372680B1 (de) 2013-04-30 2020-11-11 Novozymes A/S Glycoamylasevarianten und polynukleotide zur codierung davon
WO2014177541A2 (en) 2013-04-30 2014-11-06 Novozymes A/S Glucoamylase variants and polynucleotides encoding same
CN105164244B (zh) 2013-05-03 2019-08-20 诺维信公司 洗涤剂酶的微囊化
MX392247B (es) 2013-05-14 2025-03-24 Novozymes As Composiciones detergentes.
US20160083703A1 (en) 2013-05-17 2016-03-24 Novozymes A/S Polypeptides having alpha amylase activity
EP3004314B1 (de) 2013-05-29 2018-06-20 Danisco US Inc. Neuartige metalloproteasen
JP2016526880A (ja) 2013-05-29 2016-09-08 ダニスコ・ユーエス・インク 新規メタロプロテアーゼ
EP3004342B1 (de) 2013-05-29 2023-01-11 Danisco US Inc. Neuartige metalloproteasen
EP3260538B1 (de) 2013-05-29 2021-04-14 Danisco US Inc. Neuartige metalloproteasen
CN114634921B (zh) 2013-06-06 2024-09-10 诺维信公司 α-淀粉酶变体以及对其进行编码的多核苷酸
PE20160799A1 (es) 2013-06-12 2016-09-03 Earth Alive Clean Tech Inc Supresor de polvo
EP3019025B1 (de) 2013-06-26 2017-11-29 Novozymes A/S Verfahren zur herstellung einer futterzusammensetzung
WO2014207227A1 (en) 2013-06-27 2014-12-31 Novozymes A/S Subtilase variants and polynucleotides encoding same
WO2014207224A1 (en) 2013-06-27 2014-12-31 Novozymes A/S Subtilase variants and polynucleotides encoding same
JP2016523098A (ja) 2013-07-04 2016-08-08 ノボザイムス アクティーゼルスカブ 再付着防止効果を有するポリペプチドおよびそれをコードするポリヌクレオチド
DK3022300T3 (en) 2013-07-17 2018-10-22 Novozymes As : Pullulan chimeras and polynucleotides encoding them
CN105358686A (zh) 2013-07-29 2016-02-24 诺维信公司 蛋白酶变体以及对其进行编码的多核苷酸
EP3027747B1 (de) 2013-07-29 2018-02-07 Novozymes A/S Proteasevarianten und polynukleotide zur codierung davon
US9951364B2 (en) 2013-09-11 2018-04-24 Novozymes A/S Processes for producing fermentation products
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EP3514230B1 (de) 2013-12-13 2021-09-22 Danisco US Inc. Serinproteasen aus einer bacillus-spezies
EP3910057A1 (de) 2013-12-13 2021-11-17 Danisco US Inc. Serinproteasen des bazillus gibsonii-clade
EP4163305B1 (de) 2013-12-16 2024-07-10 Nutrition & Biosciences USA 4, Inc. Verwendung von poly-alpha-1,3-glucan-ethern als viskositätsmodifikatoren
KR102410391B1 (ko) 2013-12-18 2022-06-16 뉴트리션 앤드 바이오사이언시스 유에스에이 4, 인크. 양이온성 폴리 알파-1,3-글루칸 에테르
EP3453757B1 (de) 2013-12-20 2020-06-17 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide, die für diese kodieren
CN103834606A (zh) * 2014-01-16 2014-06-04 北京中科星冠生物技术有限责任公司 一种表达耐酸高温α-淀粉酶基因突变体的工程菌株
EP3097192B1 (de) 2014-01-22 2018-07-25 Novozymes A/S Pulluonasevarianten und polynukleotide zur codierung davon
EP3105256A1 (de) 2014-02-14 2016-12-21 E. I. du Pont de Nemours and Company Poly-alpha-1,3-1,6-glucane zur viskositätsmodifizierung
CN103789285B (zh) * 2014-02-19 2016-01-20 江南大学 一种热稳定性提高的淀粉酶突变体及其构建方法和应用
CN103805579B (zh) * 2014-02-19 2016-05-18 江南大学 一种热稳定的淀粉酶突变体及其制备方法和应用
CN106062271A (zh) 2014-03-05 2016-10-26 诺维信公司 用于改进具有木葡聚糖内糖基转移酶的纤维素纺织材料的性质的组合物和方法
CN106062270A (zh) 2014-03-05 2016-10-26 诺维信公司 使用木葡聚糖内糖基转移酶改进非纤维素纺织材料的性质的组合物和方法
US9695253B2 (en) 2014-03-11 2017-07-04 E I Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan
WO2015143144A1 (en) 2014-03-19 2015-09-24 Novozymes A/S Method for enhancing activity of an x143 polypeptide
US20170096653A1 (en) 2014-03-21 2017-04-06 Danisco Us Inc. Serine proteases of bacillus species
WO2015150457A1 (en) 2014-04-01 2015-10-08 Novozymes A/S Polypeptides having alpha amylase activity
WO2015157656A1 (en) * 2014-04-10 2015-10-15 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
CN106164236B (zh) 2014-04-11 2021-02-02 诺维信公司 洗涤剂组合物
EP3149178B1 (de) 2014-05-27 2020-07-15 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
AR100605A1 (es) 2014-05-27 2016-10-19 Novozymes As Métodos para la producción de lipasas
EP3155083B1 (de) * 2014-06-12 2021-08-11 Novozymes A/S Alpha-amylase varianten
US20170121695A1 (en) 2014-06-12 2017-05-04 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015195777A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2016001319A1 (en) 2014-07-03 2016-01-07 Novozymes A/S Improved stabilization of non-protease enzyme
EP3739029A1 (de) 2014-07-04 2020-11-18 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
EP3327122B1 (de) 2014-07-04 2021-02-17 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
DK3207129T3 (da) 2014-10-17 2020-02-24 Danisco Us Inc Serinproteaser af bacillus-arten
WO2016062875A2 (en) 2014-10-23 2016-04-28 Novozymes A/S Glucoamylase variants and polynucleotides encoding same
WO2016069552A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
US20170335306A1 (en) 2014-10-27 2017-11-23 Danisco Us Inc. Serine proteases
EP3212782B1 (de) 2014-10-27 2019-04-17 Danisco US Inc. Serinproteasen
EP4403631A3 (de) 2014-10-27 2024-10-30 Danisco US Inc. Serinproteasen
WO2016079110A2 (en) 2014-11-19 2016-05-26 Novozymes A/S Use of enzyme for cleaning
WO2016079305A1 (en) 2014-11-20 2016-05-26 Novozymes A/S Alicyclobacillus variants and polynucleotides encoding same
MX2017006695A (es) 2014-12-04 2017-08-21 Novozymes As Variantes de subtilasa y polinucleotidos que las codifican.
EP3227442B1 (de) 2014-12-05 2022-02-16 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
PL3608403T3 (pl) 2014-12-15 2025-06-23 Henkel Ag & Co. Kgaa Kompozycja detergentowa zawierająca warianty subtylazy
US20180000076A1 (en) 2014-12-16 2018-01-04 Novozymes A/S Polypeptides Having N-Acetyl Glucosamine Oxidase Activity
ES2733300T3 (es) 2014-12-17 2019-11-28 Procter & Gamble Composición detergente
EP3034589A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3034597A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3034591A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
EP3034592A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
EP3034590A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
EP3034596B2 (de) 2014-12-17 2021-11-10 The Procter & Gamble Company Reinigungsmittelzusammensetzung
EP3741849A3 (de) 2014-12-19 2021-03-17 Novozymes A/S Proteasevarianten und polynukleotide zur codierung davon
WO2016097352A1 (en) 2014-12-19 2016-06-23 Novozymes A/S Protease variants and polynucleotides encoding same
CN108064306B (zh) 2014-12-23 2022-11-01 营养与生物科学美国4公司 酶促产生的纤维素
CN107636134A (zh) 2015-04-10 2018-01-26 诺维信公司 洗涤剂组合物
WO2016162556A1 (en) 2015-04-10 2016-10-13 Novozymes A/S Laundry method, use of dnase and detergent composition
EP3872174B1 (de) 2015-05-13 2023-03-01 Danisco US Inc. Aprl-clade-protease-varianten and verwendungen davon
WO2016184944A1 (en) 2015-05-19 2016-11-24 Novozymes A/S Odor reduction
EP3101109B1 (de) 2015-06-04 2018-03-07 The Procter and Gamble Company Flüssige handspülmittelzusammensetzung
ES2665989T3 (es) 2015-06-04 2018-04-30 The Procter & Gamble Company Composición detergente líquida para lavado de vajillas a mano
EP3101107B1 (de) 2015-06-05 2019-04-24 The Procter and Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
EP3101102B2 (de) 2015-06-05 2023-12-13 The Procter & Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
HUE036591T2 (hu) 2015-06-05 2018-08-28 Procter & Gamble Kompaktált folyékony mosószerkészítmény
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
US20180134997A1 (en) 2015-06-09 2018-05-17 Danisco Us Inc. Osmotic burst encapsulates
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
EP3310908B1 (de) 2015-06-16 2020-08-05 Novozymes A/S Polypeptide mit lipaseaktivität und polynukleotide zur codierung davon
EP3310688A1 (de) 2015-06-17 2018-04-25 Novozymes A/S Behälter
EP4234693A3 (de) 2015-06-17 2023-11-01 Danisco US Inc Bacillus-gibboni-clade-serin-proteasen
US10676727B2 (en) 2015-06-18 2020-06-09 Novozymes A/S Polypeptides having trehalase activity and the use thereof in process of producing fermentation products
EP3106508B1 (de) 2015-06-18 2019-11-20 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzung mit subtilasevarianten
CN121406620A (zh) 2015-06-18 2026-01-27 诺维信公司 枯草杆菌酶变体以及编码它们的多核苷酸
WO2016135351A1 (en) 2015-06-30 2016-09-01 Novozymes A/S Laundry detergent composition, method for washing and use of composition
CA2987160C (en) 2015-07-01 2022-12-13 Novozymes A/S Methods of reducing odor
CN114292829A (zh) 2015-07-06 2022-04-08 诺维信公司 脂肪酶变体以及编码它们的多核苷酸
CA2991114A1 (en) 2015-09-17 2017-03-23 Novozymes A/S Polypeptides having xanthan degrading activity and polynucleotides encoding same
EP3350303B1 (de) 2015-09-17 2020-04-08 Henkel AG & Co. KGaA Waschmittelzusammensetzungen mit polypeptide mit xanthanabbauender aktivität
WO2017060475A2 (en) 2015-10-07 2017-04-13 Novozymes A/S Polypeptides
US10675589B2 (en) 2015-10-14 2020-06-09 Novozymes A/S Cleaning of water filtration membranes
CN108291212A (zh) 2015-10-14 2018-07-17 诺维信公司 多肽变体
US20180171318A1 (en) 2015-10-14 2018-06-21 Novozymes A/S Polypeptides Having Protease Activity and Polynucleotides Encoding Same
ES3069936T3 (en) 2015-10-28 2026-06-11 Novozymes As Detergent composition comprising amylase and protease variants
JP7364331B2 (ja) 2015-11-05 2023-10-18 ダニスコ・ユーエス・インク パエニバチルス（Ｐａｅｎｉｂａｃｉｌｌｕｓ）属種マンナナーゼ
EP4483721A3 (de) 2015-11-05 2025-04-16 Danisco US Inc. Paenibacillus und bacillus spp. mannanasen
WO2017083229A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017083226A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017083228A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
US11001821B2 (en) 2015-11-24 2021-05-11 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
EP3384019B1 (de) 2015-12-01 2020-06-24 Novozymes A/S Verfahren zur herstellung von lipasen
ES2932192T3 (es) 2015-12-07 2023-01-16 Henkel Ag & Co Kgaa Composiciones para el lavado de vajilla que comprenden polipéptidos que tienen actividad beta-glucanasa y sus usos
DK3387124T3 (da) 2015-12-09 2021-08-23 William Cuevas Kombinatoriske alfa-amylasevarianter
CN108699543B (zh) 2015-12-18 2023-07-14 丹尼斯科美国公司 具有内切葡聚糖酶活性的多肽及其用途
CN108699572A (zh) 2015-12-22 2018-10-23 诺维信公司 使用磷脂酶c增加发酵产物得率的方法
US20190002819A1 (en) 2015-12-28 2019-01-03 Novozymes Bioag A/S Heat priming of bacterial spores
US20210171927A1 (en) 2016-01-29 2021-06-10 Novozymes A/S Beta-glucanase variants and polynucleotides encoding same
EP3433347B1 (de) 2016-03-23 2020-05-06 Novozymes A/S Verwendung eines polypeptids mit dnase-aktivität zur behandlung von geweben
EP3440180B1 (de) 2016-04-08 2020-11-11 Novozymes A/S Detergenszusammensetzungen und verwendungen derselben
US10626354B2 (en) 2016-04-29 2020-04-21 Novozymes A/S Detergent compositions and uses thereof
US20190194636A1 (en) 2016-05-03 2019-06-27 Danisco Us Inc Protease variants and uses thereof
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
JP7609549B2 (ja) 2016-05-31 2025-01-07 ダニスコ・ユーエス・インク プロテアーゼ変異体およびその使用
WO2017210188A1 (en) 2016-05-31 2017-12-07 Novozymes A/S Stabilized liquid peroxide compositions
WO2017207762A1 (en) 2016-06-03 2017-12-07 Novozymes A/S Subtilase variants and polynucleotides encoding same
CN109563497A (zh) 2016-06-17 2019-04-02 丹尼斯科美国公司 蛋白酶变体及其用途
EP3257931A1 (de) 2016-06-17 2017-12-20 The Procter and Gamble Company Reinigungsmittelzusammensetzung
CN109563449B (zh) 2016-06-23 2022-01-25 诺维信公司 酶的用途、组合物以及用于去除污垢的方法
CN117721095A (zh) 2016-06-30 2024-03-19 诺维信公司 脂肪酶变体及包含表面活性剂和脂肪酶变体的组合物
WO2018002261A1 (en) 2016-07-01 2018-01-04 Novozymes A/S Detergent compositions
WO2018007573A1 (en) 2016-07-08 2018-01-11 Novozymes A/S Detergent compositions with galactanase
CN109415708A (zh) 2016-07-13 2019-03-01 宝洁公司 食物芽孢杆菌脱氧核糖核酸酶变体及其用途
CN109790525A (zh) 2016-07-18 2019-05-21 诺维信公司 脂肪酶变体、编码其的多核苷酸及其用途
ES2790148T3 (es) 2016-08-17 2020-10-27 Procter & Gamble Composición limpiadora que comprende enzimas
EP3504330A1 (de) 2016-08-24 2019-07-03 Novozymes A/S Gh9-endoglucanase-varianten und polynukleotide zur codierung davon
AU2017317564B2 (en) 2016-08-24 2021-09-30 Henkel Ag & Co. Kgaa Detergent composition comprising GH9 endoglucanase variants I
WO2018037064A1 (en) 2016-08-24 2018-03-01 Henkel Ag & Co. Kgaa Detergent compositions comprising xanthan lyase variants i
US11512300B2 (en) 2016-08-24 2022-11-29 Novozymes A/S Xanthan lyase variants and polynucleotides encoding same
CN110023474A (zh) 2016-09-29 2019-07-16 诺维信公司 酶用于洗涤的用途、洗涤方法和器皿洗涤组合物
US20190284647A1 (en) 2016-09-29 2019-09-19 Novozymes A/S Spore Containing Granule
US20210284933A1 (en) 2016-10-25 2021-09-16 Novozymes A/S Detergent compositions
US11753605B2 (en) 2016-11-01 2023-09-12 Novozymes A/S Multi-core granules
WO2018085524A2 (en) 2016-11-07 2018-05-11 Danisco Us Inc Laundry detergent composition
US10889836B2 (en) 2016-11-23 2021-01-12 Novozymes A/S Yeast for ethanol production
KR20190086540A (ko) 2016-12-01 2019-07-22 바스프 에스이 조성물 중 효소의 안정화
WO2018108865A1 (en) 2016-12-12 2018-06-21 Novozymes A/S Use of polypeptides
US20200392477A1 (en) 2016-12-21 2020-12-17 Danisco Us Inc. Protease variants and uses thereof
CN110312794B (zh) 2016-12-21 2024-04-12 丹尼斯科美国公司 吉氏芽孢杆菌进化枝丝氨酸蛋白酶
EP3577219B1 (de) 2017-02-01 2023-08-23 Novozymes A/S Alpha-amylase varianten
EP3583210B1 (de) 2017-03-15 2021-07-07 Danisco US Inc. Trypsinähnliche serinproteasen und deren verwendungen
CN110651040A (zh) 2017-03-31 2020-01-03 诺维信公司 具有dna酶活性的多肽
WO2018184004A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Alpha-amylase combinatorial variants
US11149233B2 (en) 2017-03-31 2021-10-19 Novozymes A/S Polypeptides having RNase activity
EP3601549B1 (de) 2017-03-31 2026-07-01 Novozymes A/S Polypeptide mit dnase-aktivität
EP3601515A1 (de) 2017-03-31 2020-02-05 Danisco US Inc. Enzymformulierungen mit verzögerter freisetzung für bleichmittelhaltige waschmittel
CN110651041A (zh) 2017-03-31 2020-01-03 诺维信公司 具有dna酶活性的多肽
EP3606936B1 (de) 2017-04-03 2021-10-20 Novozymes A/S Verfahren zur rückgewinnung
EP3607039A1 (de) 2017-04-04 2020-02-12 Novozymes A/S Polypeptide
CN110651029B (zh) 2017-04-04 2022-02-15 诺维信公司 糖基水解酶
WO2018185152A1 (en) 2017-04-04 2018-10-11 Novozymes A/S Polypeptide compositions and uses thereof
EP3385361B1 (de) 2017-04-05 2019-03-27 Henkel AG & Co. KGaA Waschmittelzusammensetzungen mit bakteriellen mannanasen
EP3385362A1 (de) 2017-04-05 2018-10-10 Henkel AG & Co. KGaA Waschmittelzusammensetzungen mit pilzmannanasen
US10968416B2 (en) 2017-04-06 2021-04-06 Novozymes A/S Cleaning compositions and uses thereof
DK3478811T3 (da) 2017-04-06 2020-01-27 Novozymes As Rengøringssammensætninger og anvendelser deraf
EP3607043A1 (de) 2017-04-06 2020-02-12 Novozymes A/S Reinigungszusammensetzungen und verwendungen davon
US20200032170A1 (en) 2017-04-06 2020-01-30 Novozymes A/S Cleaning compositions and uses thereof
US11499121B2 (en) 2017-04-06 2022-11-15 Novozymes A/S Detergent compositions and uses thereof
WO2018184817A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
EP3607044B1 (de) 2017-04-06 2024-11-13 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2018202846A1 (en) 2017-05-05 2018-11-08 Novozymes A/S Compositions comprising lipase and sulfite
EP3401385A1 (de) 2017-05-08 2018-11-14 Henkel AG & Co. KGaA Tensidzusammensetzungen enthaltend polypeptide enthaltend eine carbohydrate binding domain
WO2018206535A1 (en) 2017-05-08 2018-11-15 Novozymes A/S Carbohydrate-binding domain and polynucleotides encoding the same
AU2018275794A1 (en) 2017-06-02 2019-12-05 Novozymes A/S Improved yeast for ethanol production
WO2018224544A1 (en) 2017-06-08 2018-12-13 Novozymes A/S Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions
DK3645555T3 (da) 2017-06-28 2022-03-07 Novozymes As Polypeptider med trehalaseaktivitet og polynukleotider, der koder for disse
US20200181542A1 (en) 2017-06-30 2020-06-11 Novozymes A/S Enzyme Slurry Composition
WO2019006077A1 (en) 2017-06-30 2019-01-03 Danisco Us Inc PARTICLES CONTAINING LOW AGGLOMERATION ENZYME
CA3070281A1 (en) 2017-08-08 2019-02-14 Novozymes A/S Polypeptides having trehalase activity and the use thereof in process of producing fermentation products
EP3668973A2 (de) * 2017-08-18 2020-06-24 Danisco US Inc. Alpha-amylase-varianten
WO2019038058A1 (en) 2017-08-24 2019-02-28 Novozymes A/S GH9 ENDOGLUCANASE VARIANTS AND POLYNUCLEOTIDES ENCODING SUCH VARIANTS
CN111344404A (zh) 2017-08-24 2020-06-26 诺维信公司 黄原胶裂解酶变体以及编码其的多核苷酸
EP3673056A1 (de) 2017-08-24 2020-07-01 Henkel AG & Co. KGaA Waschmittelzusammensetzung mit gh9-endoglucanasevarianten ii
US20210130744A1 (en) 2017-08-24 2021-05-06 Henkel Ag & Co. Kgaa Detergent composition comprising xanthan lyase variants ii
CN111164214A (zh) 2017-09-15 2020-05-15 诺维信公司 用于改进动物饲料营养质量的酶共混物和方法
CN111247235A (zh) 2017-09-20 2020-06-05 诺维信公司 酶改善吸水性和/或白度的用途
US11414814B2 (en) 2017-09-22 2022-08-16 Novozymes A/S Polypeptides
MX2020003779A (es) 2017-09-27 2020-08-03 Procter & Gamble Composiciones detergentes que comprenden lipasas.
CN118910005A (zh) 2017-09-27 2024-11-08 诺维信公司 脂肪酶变体和包含此类脂肪酶变体的微囊组合物
CN111373036A (zh) 2017-10-02 2020-07-03 诺维信公司 具有甘露聚糖酶活性的多肽和编码它们的多核苷酸
US11746310B2 (en) 2017-10-02 2023-09-05 Novozymes A/S Polypeptides having mannanase activity and polynucleotides encoding same
CN122465671A (zh) 2017-10-16 2026-07-28 诺维信公司 低粉化颗粒
WO2019076833A1 (en) 2017-10-16 2019-04-25 Novozymes A/S PELLETS RELEASING LOW DUST QUANTITY
WO2019076800A1 (en) 2017-10-16 2019-04-25 Novozymes A/S CLEANING COMPOSITIONS AND USES THEREOF
US11326187B2 (en) 2017-10-23 2022-05-10 Novozymes A/S Processes for producing a fermentation product
EP3701001B1 (de) 2017-10-24 2026-06-10 Novozymes A/S Zusammensetzungen mit polypeptiden mit mannanase-aktivität
WO2019081724A1 (en) 2017-10-27 2019-05-02 Novozymes A/S VARIANTS OF DNASE
PL3476936T3 (pl) 2017-10-27 2022-04-11 The Procter & Gamble Company Kompozycje detergentu zawierające odmiany polipeptydowe
WO2019086532A1 (en) 2017-11-01 2019-05-09 Novozymes A/S Methods for cleaning medical devices
DE102017125560A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine iii enthalten
DE102017125558A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine i enthalten
DE102017125559A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine ii enthalten
US20200291330A1 (en) 2017-11-01 2020-09-17 Novozymes A/S Polypeptides and Compositions Comprising Such Polypeptides
WO2019086530A1 (en) 2017-11-01 2019-05-09 Novozymes A/S Polypeptides and compositions comprising such polypeptides
US11512268B2 (en) 2017-11-29 2022-11-29 Basf Se Storage-stable enzyme preparations, their production and use
US20200354708A1 (en) 2017-11-29 2020-11-12 Danisco Us Inc. Subtilisin variants having improved stability
US11725197B2 (en) 2017-12-04 2023-08-15 Novozymes A/S Lipase variants and polynucleotides encoding same
CN111742041B (zh) 2017-12-21 2023-06-06 丹尼斯科美国公司 包含耐热干燥剂的含酶的热熔细粒
MX2020007914A (es) 2018-01-29 2020-10-28 Novozymes As Microorganismos con uso de nitrogeno mejorado para produccion de etanol.
US20210071155A1 (en) 2018-02-08 2021-03-11 Novozymes A/S Lipase Variants and Compositions Thereof
US20210123033A1 (en) 2018-02-08 2021-04-29 Novozymes A/S Lipases, Lipase Variants and Compositions Thereof
BR112020016068A2 (pt) 2018-02-08 2020-12-08 Danisco Us Inc. Partículas cera termicamente resistente matriz para encapsulamento de enzima
MX2020008309A (es) 2018-02-15 2020-10-14 Novozymes As Levadura mejorada para produccion de etanol.
KR20200124258A (ko) 2018-02-23 2020-11-02 헨켈 아게 운트 코. 카게아아 크산탄 리아제 및 엔도글루카나제 변이체를 포함하는 세제 조성물
EP3765185B1 (de) 2018-03-13 2023-07-19 Novozymes A/S Mikroverkapselung unter verwendung von aminozuckeroligomeren
US12188064B2 (en) 2018-03-23 2025-01-07 Novozymes A/S Subtilase variants and compositions comprising same
EP3781660A1 (de) 2018-04-17 2021-02-24 Novozymes A/S Polypeptide mit kohlenhydratbindungsaktivität in waschmittelzusammensetzungen und ihre verwendung zur verminderung von falten in textilien oder geweben
US11566239B2 (en) 2018-04-19 2023-01-31 Novozymes A/S Stabilized cellulase variants
CN112272701B (zh) 2018-04-19 2024-05-14 诺维信公司 稳定化的纤维素酶变体
US11732250B2 (en) 2018-04-26 2023-08-22 Basf Se Lipase enzymes
US20210115422A1 (en) 2018-05-03 2021-04-22 Basf Se Amylase enzymes
WO2019231944A2 (en) 2018-05-31 2019-12-05 Novozymes A/S Processes for enhancing yeast growth and productivity
WO2019238761A1 (en) 2018-06-15 2019-12-19 Basf Se Water soluble multilayer films containing wash active chemicals and enzymes
EP3810767B1 (de) 2018-06-19 2026-07-15 Danisco US Inc. Subtilisin-varianten
EP3799601A1 (de) 2018-06-19 2021-04-07 Danisco US Inc. Subtilisinvarianten
EP3814472A1 (de) 2018-06-28 2021-05-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
US20210189297A1 (en) 2018-06-29 2021-06-24 Novozymes A/S Subtilase variants and compositions comprising same
EP3814473A1 (de) 2018-06-29 2021-05-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2020007863A1 (en) 2018-07-02 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
ES3027666T3 (en) 2018-07-03 2025-06-16 Henkel Ag & Co Kgaa Cleaning compositions and uses thereof
US20210253981A1 (en) 2018-07-06 2021-08-19 Novozymes A/S Cleaning compositions and uses thereof
WO2020008024A1 (en) 2018-07-06 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
CN112601818A (zh) 2018-07-25 2021-04-02 诺维信公司 用于生产乙醇的表达酶的酵母
WO2020028443A1 (en) 2018-07-31 2020-02-06 Danisco Us Inc Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid
EP3844255A1 (de) 2018-08-30 2021-07-07 Danisco US Inc. Enzymhaltige granulate
EP3856882A1 (de) 2018-09-27 2021-08-04 Danisco US Inc. Zusammensetzungen für die reinigung von medizinischen instrumenten
WO2020070063A2 (en) 2018-10-01 2020-04-09 Novozymes A/S Detergent compositions and uses thereof
WO2020070209A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
CN112969788A (zh) 2018-10-02 2021-06-15 诺维信公司 用于清洁的核酸内切酶1核糖核酸酶
WO2020070011A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
WO2020070014A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition comprising anionic surfactant and a polypeptide having rnase activity
WO2020070249A1 (en) 2018-10-03 2020-04-09 Novozymes A/S Cleaning compositions
CN113056476A (zh) 2018-10-03 2021-06-29 诺维信公司 具有α-甘露聚糖降解活性的多肽以及编码它们的多核苷酸
EP3861116A1 (de) 2018-10-05 2021-08-11 Basf Se Verbindungen zur stabilisierung von hydrolasen in flüssigkeiten
BR112021005412A2 (pt) 2018-10-05 2021-06-15 Basf Se preparação de enzima, processo para fabricar uma preparação de enzima estável, métodos para reduzir a perda da atividade proteolítica, para preparação de uma formulação detergente, para remover manchas e para aumentar a estabilidade na armazenagem de uma formulação detergente líquida, usos de um composto e da preparação de enzima, e, formulação detergente
EP3861114A1 (de) 2018-10-05 2021-08-11 Basf Se Verbindungen zur stabilisierung von amylasen in flüssigkeiten
EP3677676A1 (de) 2019-01-03 2020-07-08 Basf Se Verbindungen zur stabilisierung von amylasen in flüssigkeiten
WO2020076697A1 (en) 2018-10-08 2020-04-16 Novozymes A/S Enzyme-expressing yeast for ethanol production
EP3864124A1 (de) 2018-10-11 2021-08-18 Novozymes A/S Reinigungszusammensetzungen und verwendungen davon
US20210355469A1 (en) 2018-10-12 2021-11-18 Danisco Us Inc Alpha-amylases with mutations that improve stability in the presence of chelants
EP3647397A1 (de) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Reinigungsmittel mit dispersins iv
ES2981999T3 (es) 2018-10-31 2024-10-14 Henkel Ag & Co Kgaa Composiciones limpiadoras que contienen dispersinas V
CN109439607B (zh) * 2018-11-22 2020-09-04 湖南汇升生物科技有限公司 一种麦芽糖淀粉酶生产菌株的应用
US12509672B2 (en) 2018-11-28 2025-12-30 Danisco Us Inc. Subtilisin variants having improved stability
EP3891277A1 (de) 2018-12-03 2021-10-13 Novozymes A/S Waschmittelzusammensetzungen in pulverform
WO2020114965A1 (en) 2018-12-03 2020-06-11 Novozymes A/S LOW pH POWDER DETERGENT COMPOSITION
EP3898919A1 (de) 2018-12-21 2021-10-27 Novozymes A/S Waschmittelbeutel mit metalloproteasen
EP3898962A2 (de) 2018-12-21 2021-10-27 Novozymes A/S Polypeptide mit peptidoglycanabbauender aktivität und polynukleotide zur codierung davon
WO2020160126A1 (en) 2019-01-31 2020-08-06 Novozymes A/S Polypeptides having xylanase activity and use thereof for improving the nutritional quality of animal feed
EP3927809A1 (de) 2019-02-20 2021-12-29 Basf Se Industrielles fermentationsverfahren für bacillus unter verwendung eines definierten mediums und spurenelementezufuhr
EP3927837A1 (de) 2019-02-20 2021-12-29 Basf Se Industrielles fermentationsverfahren für bacillus unter verwendung eines definierten mediums und einer magnesiumzufuhr
EP3702452A1 (de) 2019-03-01 2020-09-02 Novozymes A/S Waschmittelzusammensetzungen mit zwei proteasen
BR112021018731A2 (pt) 2019-03-21 2021-12-21 Novozymes As Variantes de alfa-amilase e polinucleotídeos codificando as mesmas
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
WO2020193535A2 (en) 2019-03-25 2020-10-01 Basf Se Amylase enzymes
WO2020193534A2 (en) 2019-03-25 2020-10-01 Basf Se Amylase enzymes
WO2020206058A1 (en) 2019-04-02 2020-10-08 Novozymes A/S Process for producing a fermentation product
CN113785039B (zh) 2019-04-03 2024-06-18 诺维信公司 具有β-葡聚糖酶活性的多肽、编码其的多核苷酸及其在清洁和洗涤剂组合物中的用途
US12247237B2 (en) 2019-04-10 2025-03-11 Novozymes A/S Polypeptide variants
MX2021012289A (es) 2019-04-12 2021-11-12 Novozymes As Variantes de glucosido hidrolasa estabilizadas.
WO2020229480A1 (en) 2019-05-14 2020-11-19 Basf Se Compounds stabilizing hydrolases in liquids
CN114174504B (zh) 2019-05-24 2026-04-17 丹尼斯科美国公司 枯草杆菌蛋白酶变体和使用方法
EP3980517A1 (de) 2019-06-06 2022-04-13 Danisco US Inc. Verfahren und zusammensetzungen zum reinigen
CN113993878B (zh) 2019-06-13 2025-01-03 巴斯夫欧洲公司 用二价阳离子从发酵液中回收蛋白的方法
EP3994255A1 (de) 2019-07-02 2022-05-11 Novozymes A/S Lipasevarianten und zusammensetzungen davon
MX2022000253A (es) 2019-07-05 2022-02-03 Basf Se Proceso de fermentacion industrial para celulas microbianas mediante el uso de un precultivo de alimentacion por lotes.
CN114364778B (zh) 2019-07-12 2024-08-13 诺维信公司 用于洗涤剂的酶性乳剂
MX2021015821A (es) 2019-07-26 2022-02-03 Novozymes As Microorganismos con transporte de nitrogeno mejorado para la produccion de etanol.
EP4009807A1 (de) 2019-08-05 2022-06-15 Novozymes A/S Enzymgemische und verfahren zur herstellung eines proteinreichen futterbestandteils aus einem vollschlempennebenprodukt
MX2021015818A (es) 2019-08-06 2022-02-03 Novozymes As Proteinas de fusion para mejorar la expresion de enzimas.
CN114364795A (zh) 2019-08-22 2022-04-15 巴斯夫欧洲公司 淀粉酶变体
CN114555769A (zh) 2019-08-27 2022-05-27 诺维信公司 包含脂肪酶的组合物
WO2021037895A1 (en) 2019-08-27 2021-03-04 Novozymes A/S Detergent composition
EP4031661A1 (de) 2019-09-16 2022-07-27 Novozymes A/S Polypeptide mit beta-glucanase-aktivität und polynukleotide zur codierung davon
CN114616312A (zh) 2019-09-19 2022-06-10 诺维信公司 洗涤剂组合物
EP4038170A1 (de) 2019-10-03 2022-08-10 Novozymes A/S Polypeptide mit mindestens zwei kohlenhydratbindungsdomänen
CN114585718A (zh) 2019-10-18 2022-06-03 巴斯夫欧洲公司 储存稳定的包含水解酶的液体
BR112022007697A2 (pt) 2019-10-24 2022-07-12 Danisco Us Inc Alfa-amilase variante que forma maltopentaose/maltohexaose
CN113891931A (zh) 2019-11-29 2022-01-04 巴斯夫欧洲公司 组合物和可以用于该类组合物的聚合物
WO2021115912A1 (en) 2019-12-09 2021-06-17 Basf Se Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes
CA3158982A1 (en) 2019-12-10 2021-06-17 Monica TASSONE Microorganism for improved pentose fermentation
MX2022006438A (es) 2019-12-16 2022-06-22 Novozymes As Procesos para obtener productos de fermentacion.
US20230048546A1 (en) 2019-12-20 2023-02-16 Henkel Ag & Co. Kgaa Cleaning compositions comprising dispersins vi
EP4077656A2 (de) 2019-12-20 2022-10-26 Novozymes A/S Polypeptide mit proteolytischer aktivität und verwendung davon
EP4752205A3 (de) 2019-12-20 2026-08-19 Novozymes A/S Stabilizierte flüssige borfreie enzymzusammen setzungen
CN114829564A (zh) 2019-12-20 2022-07-29 汉高股份有限及两合公司 包含分散蛋白和糖酶的清洁组合物
WO2021122120A2 (en) 2019-12-20 2021-06-24 Henkel Ag & Co. Kgaa Cleaning compositions comprising dispersins viii
US20230407208A1 (en) 2020-01-29 2023-12-21 Conopco, Inc., D/B/A Unilever Laundry detergent product
EP4097226A1 (de) 2020-01-31 2022-12-07 Novozymes A/S Mannanase-varianten und dafür codierende polynukleotide
WO2021152123A1 (en) 2020-01-31 2021-08-05 Novozymes A/S Mannanase variants and polynucleotides encoding same
WO2021163030A2 (en) 2020-02-10 2021-08-19 Novozymes A/S Polypeptides having alpha-amylase activity and polynucleotides encoding same
EP3892708A1 (de) 2020-04-06 2021-10-13 Henkel AG & Co. KGaA Reinigungszusammensetzungen mit dispersinvarianten
EP4133066A1 (de) 2020-04-08 2023-02-15 Novozymes A/S Kohlenhydratbindende modulvarianten
CN115516071A (zh) 2020-04-21 2022-12-23 诺维信公司 包含具有果聚糖降解活性的多肽的清洁组合物
EP3907271A1 (de) 2020-05-07 2021-11-10 Novozymes A/S Reinigungszusammensetzung, verwendung und verfahren zum reinigen
WO2021239818A1 (en) 2020-05-26 2021-12-02 Novozymes A/S Subtilase variants and compositions comprising same
WO2021259099A1 (en) 2020-06-24 2021-12-30 Novozymes A/S Use of cellulases for removing dust mite from textile
EP3936593A1 (de) 2020-07-08 2022-01-12 Henkel AG & Co. KGaA Reinigungszusammensetzungen und verwendungen davon
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
EP4189051B1 (de) 2020-07-27 2024-02-28 Unilever IP Holdings B.V. Verwendung eines enzyms und eines tensids zur hemmung von mikroorganismen
JP7885201B2 (ja) 2020-08-25 2026-07-06 ノボザイムス アクティーゼルスカブ ファミリー４４キシログルカナーゼの変異体
CN116323935A (zh) 2020-08-27 2023-06-23 丹尼斯科美国公司 用于清洁的酶和酶组合物
EP4204548A1 (de) 2020-08-28 2023-07-05 Novozymes A/S Polyesterabbauende proteasevarianten
CN116113329A (zh) 2020-09-15 2023-05-12 诺维信公司 包含昆虫或昆虫粉的动物饲料
WO2022063698A1 (en) 2020-09-22 2022-03-31 Basf Se Liquid composition comprising peptide aldehyde
JP2023544111A (ja) 2020-09-22 2023-10-20 ビーエーエスエフ ソシエタス・ヨーロピア 第二の酵素を含む、プロテアーゼとプロテアーゼ阻害薬との改善された組合せ
CN116507725A (zh) 2020-10-07 2023-07-28 诺维信公司 α-淀粉酶变体
EP4232539A2 (de) 2020-10-20 2023-08-30 Novozymes A/S Verwendung von polypeptiden mit dnase-aktivität
EP4237525A1 (de) 2020-10-28 2023-09-06 Novozymes A/S Verwendung von lipoxygenase
WO2022090361A2 (en) 2020-10-29 2022-05-05 Novozymes A/S Lipase variants and compositions comprising such lipase variants
AU2021370998A1 (en) 2020-11-02 2023-05-25 Novozymes A/S Glucoamylase variants and polynucleotides encoding same
EP4244325A1 (de) 2020-11-13 2023-09-20 Novozymes A/S Waschmittelzusammensetzung mit lipase
WO2022106404A1 (en) 2020-11-18 2022-05-27 Novozymes A/S Combination of proteases
WO2022106400A1 (en) 2020-11-18 2022-05-27 Novozymes A/S Combination of immunochemically different proteases
EP4015629A1 (de) 2020-12-18 2022-06-22 Basf Se Polymermischungen zur erhöhung der stabilität und leistung von hydrolasehaltigen waschmitteln
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
EP4032966A1 (de) 2021-01-22 2022-07-27 Novozymes A/S Flüssige enzymzusammensetzung mit sulfitabfänger
EP4284905A1 (de) 2021-01-28 2023-12-06 Novozymes A/S Lipase mit geringer geruchsbildung
EP4284906A1 (de) 2021-01-29 2023-12-06 Danisco US Inc. Zusammensetzungen zur reinigung und zugehörige verfahren
EP4039806A1 (de) 2021-02-04 2022-08-10 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzung mit xanthan-lyase- und endoglucanase-varianten mit verbesserter stabilität
WO2022171780A2 (en) 2021-02-12 2022-08-18 Novozymes A/S Alpha-amylase variants
US20250075152A1 (en) 2021-02-12 2025-03-06 Novozymes A/S Stabilized biological detergents
EP4047088A1 (de) 2021-02-22 2022-08-24 Basf Se Amylasevarianten
EP4294917A1 (de) 2021-02-22 2023-12-27 Basf Se Amylasevarianten
EP4305146A1 (de) 2021-03-12 2024-01-17 Novozymes A/S Polypeptidvarianten
US20240060061A1 (en) 2021-03-15 2024-02-22 Novozymes A/S Dnase variants
EP4060036A1 (de) 2021-03-15 2022-09-21 Novozymes A/S Polypeptidvarianten
WO2022199418A1 (en) 2021-03-26 2022-09-29 Novozymes A/S Detergent composition with reduced polymer content
BR112023025624A2 (pt) 2021-06-07 2024-02-27 Novozymes As Célula de levedura recombinante, célula hospedeira recombinante, composição, cocultura, métodos de produção de um derivado de uma célula hospedeira recombinante e de produção de um produto de fermentação, e, uso de uma célula hospedeira recombinante
EP4359518A1 (de) 2021-06-23 2024-05-01 Novozymes A/S Alpha-amylase-polypeptide
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
CN117916354A (zh) 2021-09-03 2024-04-19 丹尼斯科美国公司 用于清洁的衣物洗涤组合物
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
CN118647716A (zh) 2021-12-16 2024-09-13 丹尼斯科美国公司 成麦芽五糖/麦芽六糖变体α-淀粉酶
CN118679252A (zh) 2021-12-16 2024-09-20 丹尼斯科美国公司 枯草杆菌蛋白酶变体和使用方法
EP4448750A2 (de) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisinvarianten und verwendungen davon
US20250051748A1 (en) 2021-12-16 2025-02-13 Danisco Us Inc. Subtilisin variants and methods of use
US20250028926A1 (en) 2021-12-21 2025-01-23 Basf Se Apparatus for generating a digital access element
CN118871559A (zh) 2021-12-21 2024-10-29 诺维信公司 包含脂肪酶和加强剂的组合物
EP4206309A1 (de) 2021-12-30 2023-07-05 Novozymes A/S Proteinpartikel mit verbesserter weisse
EP4234664A1 (de) 2022-02-24 2023-08-30 Evonik Operations GmbH Zusammensetzung mit glucolipiden und enzymen
EP4486858A1 (de) 2022-03-01 2025-01-08 Danisco US Inc. Enzyme und enzymzusammensetzungen zur reinigung
CN118660951A (zh) 2022-03-02 2024-09-17 诺维信公司 木葡聚糖酶用于改善洗涤剂的可持续性的用途
EP4486876A1 (de) 2022-03-04 2025-01-08 Novozymes A/S Dnase-varianten und zusammensetzungen
AU2023250091A1 (en) 2022-04-08 2024-10-03 Novozymes A/S Hexosaminidase variants and compositions
EP4532672A1 (de) 2022-06-03 2025-04-09 Unilever IP Holdings B.V. Flüssiges waschmittel
EP4544016A1 (de) 2022-06-21 2025-04-30 Danisco US Inc. Reinigungsverfahren und -zusammensetzungen mit einem polypeptid mit thermolysinaktivität
EP4544036A1 (de) 2022-06-21 2025-04-30 Novozymes A/S Mannanasevarianten und dafür codierende polynukleotide
WO2023247664A2 (en) 2022-06-24 2023-12-28 Novozymes A/S Lipase variants and compositions comprising such lipase variants
US20250376642A1 (en) 2022-07-15 2025-12-11 Basf Se Alkanolamine formates for enzyme stabilization in liquid formulations
JP2025526738A (ja) 2022-08-11 2025-08-15 ビーエーエスエフ ソシエタス・ヨーロピア アミラーゼバリアント
US20260055347A1 (en) 2022-08-11 2026-02-26 Basf Se Amylase variants
CN119855892A (zh) 2022-09-02 2025-04-18 丹尼斯科美国公司 洗涤剂组合物及其相关方法
EP4581137A1 (de) 2022-09-02 2025-07-09 Danisco Us Inc Mannanasevarianten und verfahren zur verwendung
CN120112635A (zh) 2022-09-02 2025-06-06 丹尼斯科美国公司 枯草杆菌蛋白酶变体及其相关方法
WO2024094735A1 (en) 2022-11-04 2024-05-10 Basf Se Polypeptides having protease activity for use in detergent compositions
EP4612286A1 (de) 2022-11-04 2025-09-10 Basf Se Polypeptide mit proteaseaktivität zur verwendung in waschmittelzusammensetzungen
WO2024094733A1 (en) 2022-11-04 2024-05-10 Basf Se Polypeptides having protease activity for use in detergent compositions
CN120303400A (zh) 2022-11-09 2025-07-11 丹尼斯科美国公司 枯草杆菌蛋白酶变体和使用方法
CN120989059A (zh) 2022-12-05 2025-11-21 诺维信公司 蛋白酶变体以及编码其的多核苷酸
US20260201280A1 (en) 2022-12-05 2026-07-16 Novozymes A/S A Composition Comprising A Lipase and a Peptide
EP4634355A1 (de) 2022-12-14 2025-10-22 Novozymes A/S Verbesserte lipase (gcl1)-varianten
EP4638725A1 (de) 2022-12-19 2025-10-29 Novozymes A/S Polypeptide der kohlenhydratesterasefamilie 3 (ce3) mit acetylxylanesteraseaktivität und polynukleotide zur codierung davon
EP4638767A1 (de) 2022-12-19 2025-10-29 Novozymes A/S Verfahren zur verringerung der sirupviskosität im backend eines verfahrens zur herstellung eines fermentationsprodukts
WO2024137248A1 (en) 2022-12-19 2024-06-27 Novozymes A/S Compositions comprising arabinofuranosidases and a xylanase, and use thereof for increasing hemicellulosic fiber solubilization
CN120380140A (zh) 2022-12-19 2025-07-25 诺维信公司 具有阿魏酸酯酶和/或乙酰木聚糖酯酶活性的碳水化合物酯酶家族1（ce1）多肽和编码其的多核苷酸
CN120283060A (zh) 2022-12-19 2025-07-08 诺维信公司 用于使用纤维降解酶和工程化酵母生产发酵产物的工艺
EP4389864A1 (de) 2022-12-20 2024-06-26 Basf Se Cutinasen
KR20250130619A (ko) 2022-12-23 2025-09-02 노보자임스 에이/에스 카탈라제 및 아밀라제를 포함하는 세제 조성물
WO2024146919A1 (en) 2023-01-05 2024-07-11 Basf Se Use of foldases to improve heterologous expression of secreted molecules
CN120435539A (zh) 2023-01-23 2025-08-05 诺维信公司 清洁组合物及其用途
EP4658776A1 (de) 2023-02-01 2025-12-10 Danisco US Inc. Subtilisinvarianten und verfahren zur verwendung
EP4410938A1 (de) 2023-02-02 2024-08-07 AMSilk GmbH Zusammensetzung für geschirrspülmaschinen, die ein strukturpolypeptid enthält
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
CN120813242A (zh) 2023-03-16 2025-10-17 营养与生物科学美国第四公司 用于清洁和臭味控制的短芽孢杆菌发酵物提取物及其用途
CN120882843A (zh) 2023-03-21 2025-10-31 诺维信公司 基于生物表面活性剂的洗涤剂组合物
AU2024252152A1 (en) 2023-04-12 2025-10-23 Novozymes A/S Compositions comprising polypeptides having alkaline phosphatase activity
CN120936668A (zh) 2023-04-14 2025-11-11 巴斯夫欧洲公司 多孔淀粉
EP4461796A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
EP4461795A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
CN121057807A (zh) 2023-05-11 2025-12-02 诺维信公司 包含脂肪酶的自动餐具洗涤剂组合物
AU2024303961A1 (en) 2023-06-13 2025-12-11 Novozymes A/S Processes for producing fermentation products using engineered yeast expressing a beta-xylosidase
MX2025014975A (es) 2023-06-13 2026-02-03 Basf Se Composiciones de limpieza estabilizadas que comprenden edds y enzimas y su uso
EP4735563A1 (de) 2023-06-28 2026-05-06 Novozymes A/S Lipasen enthaltende waschmittelzusammensetzung
WO2025011933A1 (en) 2023-07-07 2025-01-16 Novozymes A/S Washing method for removing proteinaceous stains
WO2025031865A1 (en) 2023-08-08 2025-02-13 Basf Se Improved bacillus cell with inactivated metalloprotease
WO2025036643A1 (en) 2023-08-15 2025-02-20 Evonik Operations Gmbh Biosurfactant for washing wool
WO2025071996A1 (en) 2023-09-28 2025-04-03 Danisco Us Inc. Variant cutinase enzymes with improved solubility and uses thereof
WO2025085351A1 (en) 2023-10-20 2025-04-24 Danisco Us Inc. Subtilisin variants and methods of use
CN122029266A (zh) 2023-10-24 2026-05-12 诺维信公司 木葡聚糖酶用于替代光学增亮剂的用途
CN122095066A (zh) 2023-11-02 2026-05-26 巴斯夫欧洲公司 含有蛋白酶抑制剂的组合物中的酶稳定
WO2025103765A1 (en) 2023-11-17 2025-05-22 Novozymes A/S Lytic polysaccharide monooxygenases and their use in detergent
WO2025114053A1 (en) 2023-11-30 2025-06-05 Novozymes A/S Biopolymers for use in detergent
WO2025128568A1 (en) 2023-12-11 2025-06-19 Novozymes A/S Composition and use thereof for increasing hemicellulosic fiber solubilization
CN122422502A (zh) 2023-12-20 2026-07-17 巴斯夫欧洲公司 包含蛋白酶的稳定的酶组合物
CN122555763A (zh) 2024-01-19 2026-08-11 诺维信公司 洗涤剂组合物及其用途
WO2025202369A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202370A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202379A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202372A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202374A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
EP4624572A1 (de) 2024-03-27 2025-10-01 Basf Se Polypeptide mit proteaseaktivität zur verwendung in waschmittelzusammensetzungen
WO2025257254A1 (en) 2024-06-12 2025-12-18 Novozymes A/S Lipases and lipase variants and the use thereof
WO2026008449A2 (en) 2024-07-04 2026-01-08 Novozymes A/S A process for producing a fermentation product and a concentrated protein co-product
WO2026017636A1 (en) 2024-07-17 2026-01-22 Novozymes A/S Compositions comprising combination of enzymes
WO2026024922A1 (en) 2024-07-25 2026-01-29 Danisco Us Inc. Subtilisin variants and methods of use
WO2026032785A1 (en) 2024-08-06 2026-02-12 Evonik Operations Gmbh Bacillus licheniformis strains in cleaning and animal feeding
EP4692292A1 (de) 2024-08-06 2026-02-11 Evonik Operations GmbH Verbessertes verfahren zur keimung von bakteriensporen
WO2026046881A1 (en) 2024-08-26 2026-03-05 Novozymes A/S Compositions comprising a hexosaminidase and a protease
WO2026050315A1 (en) 2024-08-29 2026-03-05 Danisco Us Inc. Subtilisin variants and methods of use
WO2026068782A1 (en) 2024-09-30 2026-04-02 Novozymes A/S Protease variants and polynucleotides encoding same
WO2026093440A1 (en) 2024-11-04 2026-05-07 Novozymes A/S Protease variants and compositions comprising same
WO2026109480A1 (en) 2024-11-25 2026-05-28 Novozymes A/S Gh26 mannanases and their use in detergent
WO2026128769A1 (en) 2024-12-13 2026-06-18 Danisco Usa Inc. Cleaning compositions comprising bacterial fermentate extracts and methods related thereof
WO2026128766A1 (en) 2024-12-13 2026-06-18 Danisco Usa Inc. Malodor control compostions comprising bacterial fermentate extracts and methods related thereof
CN122256324A (zh) 2024-12-23 2026-06-23 巴斯夫欧洲公司 共混物中酶的副产物失活
DE202025107340U1 (de) 2025-08-13 2026-06-03 Dalli-Werke Gmbh & Co. Kg Wässrige flüssige Handgeschirrspülzusammensetzung

Citations (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912590A (en) 1973-01-03 1975-10-14 Novo Industri As Procedure for liquefying starch
EP0063909A1 (de) 1981-04-20 1982-11-03 Novo Nordisk A/S Zur Abspaltung von Seitenketten befähigtes Enzymprodukt
EP0119920A2 (de) 1983-03-22 1984-09-26 Elf Atochem S.A. Verfahren zum gleichzeitigen Entschlichten und Bleichen von Textilien
US4643736A (en) 1981-01-23 1987-02-17 Produits Chimiques Ugine Kuhlmann Desizing and bleaching woven fabrics in a single operation in a bath based on sodium chlorite
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
EP0252730A2 (de) 1986-07-09 1988-01-13 Novo Nordisk A/S Mischungen von Alpha-Amylase zur Verflüssigung von Stärke
EP0252666A2 (de) 1986-06-30 1988-01-13 Novo Nordisk A/S Chimäre Enzyme
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
WO1991000353A2 (en) 1989-06-29 1991-01-10 Gist-Brocades N.V. MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY
WO1991017243A1 (en) 1990-05-09 1991-11-14 Novo Nordisk A/S A cellulase preparation comprising an endoglucanase enzyme
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
WO1994018314A1 (en) 1993-02-11 1994-08-18 Genencor International, Inc. Oxidatively stable alpha-amylase
WO1995010603A1 (en) 1993-10-08 1995-04-20 Novo Nordisk A/S Amylase variants
WO1995021247A1 (en) 1994-02-02 1995-08-10 Novo Nordisk A/S The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process
WO1995022625A1 (en) 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1995026397A1 (en) 1994-03-29 1995-10-05 Novo Nordisk A/S Alkaline bacillus amylase
WO1996000343A1 (de) 1994-06-24 1996-01-04 Audi Ag Verfahren zum steuern der elektrischen beheizung eines katalysators
WO1996023874A1 (en) 1995-02-03 1996-08-08 Novo Nordisk A/S A method of designing alpha-amylase mutants with predetermined properties
WO1996028567A1 (en) 1995-03-09 1996-09-19 Genencor International, Inc. Method for liquefying starch
WO1997000324A1 (en) 1995-06-14 1997-01-03 Kao Corporation Gene encoding alkaline liquefying alpha-amylase
WO1997007202A1 (en) 1995-08-11 1997-02-27 Novo Nordisk A/S Novel lipolytic enzymes
WO1999019467A1 (en) 1997-10-13 1999-04-22 Novo Nordisk A/S α-AMYLASE MUTANTS
WO1999028448A1 (en) 1997-11-26 1999-06-10 Novo Nordisk A/S Thermostable glucoamylase
WO2000004136A1 (en) 1998-07-15 2000-01-27 Novozymes A/S Glucoamylase variants
EP1022334A2 (de) 1998-12-21 2000-07-26 Kao Corporation Neue Amylasen
WO2000060060A2 (en) 1999-03-31 2000-10-12 Novozymes A/S Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
WO2001004273A2 (en) 1999-07-09 2001-01-18 Novozymes A/S Glucoamylase variant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
AR000862A1 (es) * 1995-02-03 1997-08-06 Novozymes As Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del
AU2692897A (en) * 1996-04-30 1997-11-19 Novo Nordisk A/S Alpha-amylase mutants
US6080568A (en) * 1997-08-19 2000-06-27 Genencor International, Inc. Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
US6197565B1 (en) * 1998-11-16 2001-03-06 Novo-Nordisk A/S α-Amylase variants
JP4077095B2 (ja) * 1998-12-21 2008-04-16 花王株式会社 新規アミラーゼ
AU3419300A (en) * 1999-03-30 2000-10-23 Novozymes A/S Alpha-amylase variants
JP4417532B2 (ja) * 1999-06-10 2010-02-17 花王株式会社 変異α−アミラーゼ
WO2002031124A2 (en) 2000-10-13 2002-04-18 Novozymes A/S Alpha-amylase variant with altered properties

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912590A (en) 1973-01-03 1975-10-14 Novo Industri As Procedure for liquefying starch
US4643736A (en) 1981-01-23 1987-02-17 Produits Chimiques Ugine Kuhlmann Desizing and bleaching woven fabrics in a single operation in a bath based on sodium chlorite
EP0063909A1 (de) 1981-04-20 1982-11-03 Novo Nordisk A/S Zur Abspaltung von Seitenketten befähigtes Enzymprodukt
EP0119920A2 (de) 1983-03-22 1984-09-26 Elf Atochem S.A. Verfahren zum gleichzeitigen Entschlichten und Bleichen von Textilien
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683202B1 (de) 1985-03-28 1990-11-27 Cetus Corp
EP0252666A2 (de) 1986-06-30 1988-01-13 Novo Nordisk A/S Chimäre Enzyme
EP0252730A2 (de) 1986-07-09 1988-01-13 Novo Nordisk A/S Mischungen von Alpha-Amylase zur Verflüssigung von Stärke
WO1991000353A2 (en) 1989-06-29 1991-01-10 Gist-Brocades N.V. MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY
WO1991017243A1 (en) 1990-05-09 1991-11-14 Novo Nordisk A/S A cellulase preparation comprising an endoglucanase enzyme
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
WO1994018314A1 (en) 1993-02-11 1994-08-18 Genencor International, Inc. Oxidatively stable alpha-amylase
WO1995010603A1 (en) 1993-10-08 1995-04-20 Novo Nordisk A/S Amylase variants
WO1995021247A1 (en) 1994-02-02 1995-08-10 Novo Nordisk A/S The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process
WO1995022625A1 (en) 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1995026397A1 (en) 1994-03-29 1995-10-05 Novo Nordisk A/S Alkaline bacillus amylase
WO1996000343A1 (de) 1994-06-24 1996-01-04 Audi Ag Verfahren zum steuern der elektrischen beheizung eines katalysators
WO1996023874A1 (en) 1995-02-03 1996-08-08 Novo Nordisk A/S A method of designing alpha-amylase mutants with predetermined properties
WO1996028567A1 (en) 1995-03-09 1996-09-19 Genencor International, Inc. Method for liquefying starch
WO1997000324A1 (en) 1995-06-14 1997-01-03 Kao Corporation Gene encoding alkaline liquefying alpha-amylase
WO1997007202A1 (en) 1995-08-11 1997-02-27 Novo Nordisk A/S Novel lipolytic enzymes
WO1999019467A1 (en) 1997-10-13 1999-04-22 Novo Nordisk A/S α-AMYLASE MUTANTS
WO1999028448A1 (en) 1997-11-26 1999-06-10 Novo Nordisk A/S Thermostable glucoamylase
WO2000004136A1 (en) 1998-07-15 2000-01-27 Novozymes A/S Glucoamylase variants
EP1022334A2 (de) 1998-12-21 2000-07-26 Kao Corporation Neue Amylasen
WO2000060060A2 (en) 1999-03-31 2000-10-12 Novozymes A/S Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
WO2001004273A2 (en) 1999-07-09 2001-01-18 Novozymes A/S Glucoamylase variant

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BOEL ET AL.: "Glucoamylases G1 and G2 from Aspergillus niger are synthesized from two different but closely related mRNAs", EMBO J., vol. 3, no. 5, 1984, pages 1097 - 1102
GABORIAUD ET AL., FEBS LETTERS, vol. 224, 1987, pages 149 - 155
HUBER, T; TORDA, AE, PROTEIN SCIENCE, vol. 7, no. 1, 1998, pages 142 - 149
KIRCHHOFF; DESROSIERS, PCR METHODS AND APPLICATIONS, vol. 2, 1993, pages 301 - 304
MATTHES ET AL., EMBO J., vol. 3, 1984, pages 801 - 805
NEEDLEMAN; WUNSCH, J.MOL. BIOL., vol. 48, 1970, pages 443 - 453
R.K. SAIKI ET AL., SCIENCE, vol. 239, 1988, pages 487 - 491
S.L. BEAUCAGE; M.H. CARUTHERS, TETRAHEDRON LETTERS, vol. 22, 1981, pages 1859 - 1869
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual, 2nd Ed.,", 1989, COLD SPRING HARBOR
SHAFIKHANI ET AL., BIOTECHNIQUES, vol. 23, 1997, pages 304 - 310
TSUKAMOTO ET AL., BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 151, 1988, pages 25 - 31

Also Published As

Publication number Publication date
AR076940A2 (es) 2011-07-20
JP4855632B2 (ja) 2012-01-18
CA2416967A1 (en) 2002-02-07
AR028979A1 (es) 2003-05-28
EP1370648A2 (de) 2003-12-17
EP2308980A2 (de) 2011-04-13
JP2011224015A (ja) 2011-11-10
EP2204446A1 (de) 2010-07-07
CN1529752A (zh) 2004-09-15
EP2298903A3 (de) 2011-10-05
EP2308979A3 (de) 2011-05-04
EP2308980A3 (de) 2011-04-27
WO2002010355A2 (en) 2002-02-07
EP2180035A1 (de) 2010-04-28
CN101857858A (zh) 2010-10-13
AU2001278415A1 (en) 2002-02-13
JP2004508815A (ja) 2004-03-25
CA2778199A1 (en) 2002-02-07
EP2298903A2 (de) 2011-03-23
WO2002010355A3 (en) 2003-09-12
CA2702204A1 (en) 2002-02-07
CA2702204C (en) 2011-09-06
CA2416967C (en) 2014-02-18

Similar Documents

Publication Publication Date Title
CA2702204C (en) Alpha-amylase mutants with altered properties
US7713723B1 (en) Alpha-amylase mutants with altered properties
RU2231547C2 (ru) Варианты альфа-амилазы
US9920307B2 (en) Alpha-amylase variants with altered properties
CA2305191C (en) .alpha.-amylase mutants
EP1423513B1 (de) Alpha-amylasevariante mit veränderten eigenschaften
EP1131418B1 (de) Alpha-amylase-varianten
US8465957B2 (en) Alpha-amylase variants
WO2001088107A2 (en) Alpha-amylase variants with altered 1,6-activity
US20020068352A1 (en) Alpha-amylase variants with altered 1, 6-activity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

17P Request for examination filed

Effective date: 20100928

AC Divisional application: reference to earlier application

Ref document number: 1370648

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20120618

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160301